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Alkylresorcinols (AR) are phenolic lipids present in the outer parts of rye and wheat 
grain kernels. Total AR concentration and the ratio of two AR homologs, 
C17:0/C21:0, in plasma have been evaluated and used as biomarkers of whole grain 
rye and wheat intake. The AR C17:0/C21:0 ratio is 1.0 in rye and 0.1 in common 
wheat and reflects the relative intake of whole grain rye. However, due to the short 
half-life (4-5 h) of AR in plasma, more long-term biomarkers are needed. 
   This thesis investigated whether AR in adipose tissue could be used as long-term 
biomarkers of whole grain wheat and rye intake, and whether these biomarkers, in 
parallel with whole grain intakes determined by dietary assessment, were associated 
with blood lipid profiles and breast cancer incidence in two Nordic populations. 
   A sensitive, high-throughput GC-MS method for quantification of AR 
concentrations in adipose tissue biopsies was developed, evaluated, and applied. The 
AR concentrations in adipose tissue were evaluated as long-term biomarkers by 
correlating them to whole grain intake, measured precisely by repeated food records 
during a 12-week intervention, and to long-term whole grain wheat and rye intake 
estimated with food frequency questionnaires (FFQs) in observational studies. 
Intake was found to be modestly to well correlated with total AR concentrations in 
adipose tissue, with sex being an important determinant. The performance of AR in 
adipose tissue as biomarkers of whole grain wheat and rye appeared comparable to 
that of AR in plasma, and therefore they were further tested in relation to blood lipid 
profiles and incidence of breast cancer in two observational studies.   
   Overall, total whole grain wheat and rye, reflected by biomarkers or dietary 
assessment, were not associated with blood lipids or breast cancer incidence in the 
populations studied. However, AR C17:0/C21:0 ratio in adipose tissue was inversely 
associated with low-density lipoprotein cholesterol (LDL-C) in blood and positively 
associated with the risk of developing ER+ breast cancer among women. These 
findings suggest that whole grain wheat and rye may have different effects on the 
endpoints studied but need to be confirmed in other population. The results illustrate 
the importance of using dietary biomarkers in parallel with conventional dietary 
assessment. 
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Non-communicable diseases are major threats to sustainable development 
globally and are estimated to have account for around 60% of all deaths in 2002 
(WHO, 2005), 63% in 2008 (WHO, 2013), and 70% in 2015 (WHO, 2017), 
while the number is projected to increase to 73% by 2020 (WHO, 2005). 
Cardiovascular disease (CVD) (17.7 million deaths) and cancer (9.0 million 
deaths) are the two leading causes of death world-wide (WHO, 2017). 
   CVD is strongly affected by lifestyle (Lichtenstein et al., 2006). A number of 
behavioral risk factors, including alcohol and tobacco use, physical inactivity, 
an unhealthy diet with excess salt, fat, and energy, and metabolic risk factors, 
such as elevated blood pressure, blood sugar, blood lipids, and body weight, 
play major roles in development of CVD (Mendis et al., 2011). Despite high 
mortality rates, CVD mortality has been significantly reduced in high-income 
countries (Western Europe, North America, Australia, New Zealand, Japan, and 
the Republic of Korea), due to promotion of a healthy lifestyle and good 
healthcare. An increase in mortality is mainly seen in middle- and low-income 
countries, where it is related to an unhealthy lifestyle and rising life expectancy 
(WHO, 2014).  
   Cancer is also highly affected by lifestyle factors, including diet (Willett, 
2002, Willett et al., 2006). Breast cancer is the most common cancer among 
women (25% of all cancers in female) with 1.7 million new cases and 0.5 
million deaths in 2012 (Stewart and Wild, 2014). Breast cancer risk factors 
include age (higher at younger ages), age at menarche and menopause 
(increased risk for earlier menarche and/or later menopause ), age at first 
pregnancy (risk of breast cancer for women have their first child at age: before 
20 < after 30 < after 35), family history (including BRCA1, BRCA2, and other 
genes), previous benign breast disease (severe atypical epithelial hyperplasia), 
exposed to radiation (mainly during the World War II), use of oral 
contraceptives, hormone replacement therapy (HRT), use of alcohol 
(McPherson et al., 2000), and infection with human mammary tumor virus 
1 Background 
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(Holland and Pogo, 2004, Liu et al., 2001, Pogo et al., 2010). Based on 
expression of estrogen receptor, breast cancer can be divided into estrogen-
receptor-positive (ER+) and estrogen-receptor-negative (ER-) subsets, where 
the former responds better to endocrine therapy and lifestyle change (Rugo et 
al., 2016). 
1.1 Whole grains and health 
Much attention has been devoted to the role of nutrients in prevention of non-
communicable disease and reducing mortality in the past (Garland and Garland, 
1980, Trowell, 1972). More recently, attention has turned to the role of foods 
and food patterns to a greater extent (Hu, 2002). 
   Cereals are important staple foods and are the main source of energy intake in 
the US and Europe (O’Neil et al., 2012, Ocke et al., 2009). During the past 100 
years, cereals have generally been consumed as refined grains, which mainly 
consist of starchy endosperm. Whole grain, on the other hand, contains all parts 
of the grain, i.e., the starchy endosperm, bran, and germ, and is a rich source of 
nutrients (Table 1), including vitamins (Melanson et al., 2006), dietary fibers 
(Turner and Lupton, 2011), unsaturated fatty acids (Slavin, 2003), and 
phytochemicals (Liu, 2007), and minerals (Melanson et al., 2006). 
Accumulating data, mainly from observational studies, suggests beneficial 
health effects of whole grain foods, and increased intake is therefore 
recommended by national dietary guidelines in many countries (Slavin et al., 
2016). For example, in the latest Nordic Nutrition Recommendations 2012, 
refined cereals are recommended to be replaced with whole grain cereals to 
reduce disease risk and sustain health (Becker et al., 2013).  
   A common definition of whole grain that has been used in many countries, 
including in the Nordic Nutrition Recommendations, is that provided by the 
American Association of Cereal Chemists (AACC) from 1999:  
 
  “Whole grains shall consist of the intact, ground, cracked or flaked caryopsis, 
whose principal anatomical components-the starchy endosperm, germ, and 
bran-are present in the same relative proportions as they exist in the intact 
caryopsis.” 
 
   The AACC definition include caryopses from a broad range of grains classified 
into three groups: (1) Cereals: wheat, triticale, rye, corn, barley, oats, millet, 
sorghum, and rice; (2) pseudocereals, including amaranth, buckwheat and 
quinoa; and (3) wild rice.  
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Table 1. Nutrient composition (per 100 g) of refined wheat and common whole grains cereals1 
Nutrient  Unit  Refined wheat  Wheat  Rye  Oat  Buckwheat  Corn  Barley  Brown rice  Millet 
Energy  kcal  361  340  325  404  335  361  345  363  382 
Protein  g  12.0  13.2  15.9  14.7  12.6  6.9  10.5  7.2  10.8 
Total lipids  g  1.7  2.5  2.2  9.1  3.1  3.9  1.6  2.8  4.3 
SFA2  g  0.2  0.4  0.3  1.6  0.7  0.5  0.3  0.6  0.5 
MUFA2  g  0.1  0.3  0.3  2.9  0.9  1.0  0.2  1.0  0.9 
PUFA2  g  0.7  1.2  1.0  3.3  0.9  1.8  0.8  1.0  2.6 
Carbohydrate  g  72.5  72.0  68.6  65.7  70.6  76.9  74.5  76.5  75.1 
Dietary fiber  g  2.4  10.7  23.8  6.5  10.0  7.3  10.1  4.6  3.5 
Sugars  g  0.3  0.4  2.3  0.8  2.6  0.6  0.8  0.7  1.7 
Calcium  mg  15  34  37  55  41  7  32  11  14 
Iron  mg  0.9  3.6  5.0  4.0  4.1  2.4  2.7  2.0  3.9 
Magnesium  mg  25  137  160  144  251  93  96  112  119 
Phosphorus  mg  97  357  499  452  337  272  296  337  285 
Potassium  mg  100  363  717  371  577  315  309  289  224 
Sodium  mg  2  2  2  19  11  5  4  8  4 
Zinc  mg  0.9  2.6  5.0  3.2  3.1  1.7  2.0  2.5  2.6 
Thiamin  mg  0.08  0.50  0.32  0.69  0.42  0.25  0.37  0.44  0.41 
Riboflavin  mg  0.06  0.17  0.25  0.13  0.19  0.08  0.11  0.08  0.07 
Niacin  mg  1.0  5.0  4.3  1.5  6.2  1.9  6.3  6.3  6.0 
Vitamin B‐6  mg  0.04  0.41  0.44  0.13  0.58  0.37  0.40  0.74  0.37 
Folate  µg  33  44  33  32  54  25  8  16  42 
Vitamin E  mg  0.4  0.7  2.7  0.7  0.3  0.4  0.6  0.6  0.1 
Vitamin K  µg  0.3  1.9  5.9  3.2  7  0.3  2.2  0.8 
1 Data from the National nutrient database for standard reference Release 28 (USDA, 2017).  
2 SFA, saturated fatty acids; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid 
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   However, there is currently no widely accepted definition of a whole grain 
product. The HEALTHGRAIN Forum recently proposed a definition of a whole 
grain product as: “A whole-grain food is one for which the product is made with 
≥30% whole-grain ingredients on a dry-weight basis and more whole-grain 
ingredients than refined-grain ingredients” (Ross et al., 2017b). From a 
scientific point of view, the amount of whole grain consumed per day may be of 
greatest relevance in relation to health outcomes (Aune et al., 2016). It is 
therefore crucial that whole grain consumption can be estimated accurately. 
   The evidence of beneficial health effects of whole grains used to justify the 
dietary guidelines is primarily based on results from observational studies. 
Observational studies have consistently shown that high whole grain intake is 
inversely associated with risk of CVD (Aune et al., 2016, Jacobs and Gallaher, 
2004, Mellen et al., 2008, Wu et al., 2015), type 2 diabetes (Cho et al., 2013, 
Meyer et al., 2000, Salmerón et al., 1997, Ye et al., 2012), and colorectal cancer 
(Aune et al., 2016, Chatenoud et al., 1998, Jacobs et al., 1998). There is yet a 
number of outcomes where a protective role of whole grains has been suggested 
and investigated based on plausible hypotheses, but where results remain 
inconclusive. Breast cancer is one such outcome. 
1.1.1 Whole grains and cardiovascular disease  
A recent meta-analysis suggested that three daily servings of whole grains was 
associated with a 19, 12 and 22% lower risk of developing coronary heart 
disease, stroke and total CVD, respectively (Aune et al., 2016). Despite large 
differences in the types of grains consumed in different parts of the world (Table 
2), studies included in the meta-analysis (Aune et al., 2016) consistently show 
protective associations for a wide range of types and amount of grains consumed 
(Table 3).   
 
Table 2. The most commonly consumed whole grains from different parts of the world reported in 
some studies. 
Country Whole grain  Reference 
Sweden Wheat (14-19%), rye (53-56%), and oats (15-16%) (Kyrø et al., 2012) 
Norway Wheat (72%), rye (20%), and oats (6%) (Kyrø et al., 2012) 
Denmark Wheat (8-10%), rye (71-73%), and oats (15-19%) (Kyrø et al., 2012) 
US Wheat, corn, oats, barley and rice  (Jonnalagadda et al., 2011) 
France Wheat, oats and buckwheat (Bellisle et al., 2014) 
China Corn and sorghum  (Wang et al., 2016) 
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Table 3: Whole grain intake and risk of cardiovascular disease in different regions of the world 
Region  n  Quantity of intake  Outcomes  Reference 
US  75 521 women   1.77 serving/d vs. less than 0.26 serving/d of whole grain 
33% lower in 
Coronary heart 
disease 
incidence 
(Liu et al., 
1999) 
US  75 521 women   1.77 serving/d vs. less than 0.26 serving/d 
30‐40% lower 
ischemic stroke 
incidence 
(Liu et al., 
2000) 
US 
75 521 women 
and 43 744 
men  
Highest quintile with median 
33.0 g/d for women and 47.8 
g/d for men vs. lowest quintile 
with median 4.2 g/d for women 
and 5.9 g/d for men 
15% lower CVD 
mortality  
(Wu et al., 
2015) 
US  566 399 men and women 
Higher intake quintile with 
median 34.0 g/d vs. lowest 
quintile with median 3.7 g/d 
17% lower CVD 
mortality 
(Huang et al., 
2015) 
US  535 subjects 
Higher intake quintile with 
median 2.9 serving/d vs. lowest 
quintile with median 0.31 
serving/d 
52% lower CVD 
mortality 
(Sahyoun et 
al., 2006) 
US  11 940 subjects 
Higher intake quintile with 
median 3 serving/d vs. lowest 
quintile with median 0.1 
serving/d 
28% lower CAD 
incidence 
(Steffen et al., 
2003) 
US  34 827 women  
Quintiles of whole grain divided 
by DASH Score: higher intake 
quintile with mean 2.33 
serving/d vs. lowest quintile 
with mean 0.78 serving/d 
Not significant   (Fitzgerald et al., 2012) 
Norway, 
Sweden 
and 
Denmark 
120 010 men 
and women  Per doubling in intake 
20% (women) or 
10% (men) lower 
CHD mortality 
(Johnsen et 
al., 2015) 
Sweden  32 561 women  Per 90g/day increase   22% lower  CVD mortality 
(Rautiainen et 
al., 2012) 
Finland  3 932 men and women 
Highest quintile 195‐963 g/d 
for women and 280‐1321 g/d 
for men vs. lowest quintile 0‐89 
g/d for women and 0‐139 g/d 
for men  
Not significant   (Mizrahi et al., 2009) 
Spain  7 447 men and women 
Higher intake quintile with 
median 84 g/d vs. lowest 
quintile with mean 0 g/d 
Not significant  
(Buil-
Cosiales et 
al., 2014) 
China  1 104 men and 1 341 women  Per once/d  Not significant  
(Wang et al., 
2016)  
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Potential mediators of beneficial effects of whole grains on cardiovascular 
disease 
The observed protective role of whole grains on CVD might be mediated through 
effects on body weight, blood pressure, glycemic control, blood lipids and 
inflammation which are all recognized as cardiometabolic risk factors (Behall et 
al., 2006, Dudina et al., 2011, Esmaillzadeh et al., 2004, Jensen et al., 2006, 
McKeown et al., 2002, Montonen et al., 2013, Qi et al., 2006, Tighe et al., 2010). 
One of the most established mechanism of protective effects of whole grains on 
CVD is through total cholesterol (TCHOL) and LDL-C reduction caused by 
viscous dietary fiber and phytosterols (Hunninghake et al., 1994, Ripsin et al., 
1992). The cholesterol lowering effect has been shown for beta-glucans from 
oats and barley and there are approved health claims in Europe (Agostoni et al., 
2011). Whole grain foods are good source of phytosterols (Ostlund and Lin, 
2006) and intakes of 2.3 ± 0.5 g/d have been shown to lower TCHOL and LDL-
C by 7-11% and 10-15%, respectively (Moruisi et al., 2006). 
   Whole grain foods with well-preserved structure and a high content of viscous 
fiber could also delay the absorption of macronutrients, leading to better 
glycemic control (Cara et al., 1992, Hallfrisch et al., 1995). Moreover, whole 
grain intake could reduce total energy intake, as well as increase short-chain fatty 
acid production from gut microbiota (Clark and Slavin, 2013, Cooper et al., 
2015). However, the joint or separate role of whole grain wheat and rye for most 
of the mechanisms above remains yet unclear due to few studies (Hollaender et 
al., 2015, Nilsson et al., 2008, Rosén et al., 2011, Slavin et al., 1999, Ye et al., 
2012). 
1.1.2 Whole grains and breast cancer 
Although whole grain intake has been hypothesized to have a protective role for 
development of breast cancer (Jacobs et al., 1995), the overall association 
between intake of whole grain or cereal fiber and risk of breast cancer is 
inconsistent and may be affected by the use of hormone replacement therapy and 
menopausal status (Table 4). 
 
Suggested mechanisms for impact of whole grain intake on breast cancer  
Whole grain-derived dietary fiber and lignans may play roles in preventing the 
development of breast cancer (Adlercreutz, 2010, Jacobs et al., 1995, Slavin, 
2000). Dietary fiber can interfere with estrogen metabolism and interrupt 
reabsorption of estrogens and their precursors in the intestine (Arts et al., 1991a, 
Arts et al., 1992, Braaten et al., 1994), while plant lignans can be metabolized 
by the mammalian microflora to enterolactone and enterodiol, which have 
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Table 4. Whole grain and cereal fiber intake and risk of breast cancer in different studies.  
 
Region  n  Quantity of intake  Outcomes  Reference 
Denmark  25 278 
Whole grain product intake: highest 
quintile (more than 163  g/d) vs 
lowest quintile (less than 72 g/d) 
Not significant  (Egeberg et al., 2009)  
Greece  500  Whole grain intake: more than 7 times/week vs Never/rarely 
51% lower  breast 
incidence 
(Mourouti et 
al., 2016) 
US  90 534 
Whole grain intake: highest quintile 
(44.8±16.8 g/d) vs lowest quintile 
(2.8±2.0 g/d) 
26% lower 
premenopausal 
breast cancer  
incidence 
(Farvid et 
al., 2016) 
US  29 119 
Whole grain intake: highest quintile 
(19‐108.5  g/d) vs lowest quintile (0‐
3.5 g/d) 
Not significant  (Nicodemus et al., 2001) 
Denmark, 
France, 
Germany, 
Greece, Italy, 
Norway, Spain, 
Sweden, the 
Netherlands, 
and UK 
334 849 
Cereal fiber intake: highest quintile 
(more than 10.9  g/d) vs lowest 
quintile (less than 4.7 g/d) 
Not significant  (Ferrari et al., 2013) 
UK  35 792 
Cereal fiber intake: highest quintile 
(more than 13 g/d) vs lowest quintile 
(less than 4g/d) 
Not significant  (Cade et al., 2007) 
France  4 684 
Cereal fiber intake: highest quintile 
(more than 7.7 g/d) vs lowest 
quintile (less than 4.4 g/d) 
Not significant  (Deschasaux et al., 2013) 
Canada  89 835 
Cereal fiber intake: highest quintile 
(more than 5.6  g/d) vs lowest 
quintile (less than 2.6 g/d) 
Not significant  (Terry et al., 2002) 
US  88 678 
Cereal fiber intake: highest quintile 
(median 8.4  g/d) vs lowest quintile 
(median 2.4 g/d) 
Not significant  (Holmes et al., 2004) 
US  116 671 
Cereal fiber intake: highest quintile 
(median 8.8  g/d) vs lowest quintile 
(median 4.2 g/d) 
Not significant  (Cho et al., 2003) 
US  185 598 
Cereal fiber intake: highest quintile 
(median 8.9  g/d) vs lowest quintile 
(median 2.5 g/d) 
Not significant  (Park et al., 2009) 
Sweden  51 823 
Cereal fiber intake: highest quintile 
(median 21.5  g/d) vs lowest quintile 
(median 10.4 g/d) 
50% lower 
incidence among 
former use of 
postmenopausal 
hormone 
(Suzuki et 
al., 2008) 
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phytoestrogenic effects and can affect estrogen binding and signaling (Arts et 
al., 1991a, Arts et al., 1992, Arts et al., 1991b, Damdimopoulou, 2008, Granata 
et al., 2009, Illman et al., 1993, Warner  and Gustafsson 2014). 
1.1.3 The potential role of individual whole grains on health 
Most of the epidemiological studies on whole grain and health, have typically 
investigated the role of total whole grain intake, whereas the specific role of 
different whole grains have been less investigated (Kyrø et al., 2013, Kyrø et al., 
2014b). Grains differ considerably in their content and composition of nutrients 
and bioactive compounds (Table 1) and the type of grains consumed varies 
worldwide (van der Kamp et al., 2014) (Table 2). Among the different whole 
grains, wheat and rye are most commonly consumed in the Nordic countries 
(Engeset et al., 2015), but their separate role, particularly the role of rye, remains 
yet unclear due to few studies (Hollaender et al., 2015, Nilsson et al., 2008, 
Rosén et al., 2011, Slavin et al., 1999, Ye et al., 2012). 
   Compared with whole grain wheat, whole grain rye contains higher amounts 
of total and viscosity forming dietary fiber (Andersson et al., 2013, Hansen et 
al., 2003, Saastamoinen et al., 1989) and phytosterols (1098-1420 µg/g in rye 
vs. 670-959 µg/g in wheat). Whole grain rye may therefore play a more important 
role for cholesterol lowering effects than whole grain wheat. Moreover, whole 
grain rye, but not other cereals to the same extent, is a rich source of lignans that 
are converted to enterolactone and enterodiol that have estrogenic and 
antiestrogenic effects (Andersson et al., 2013, Nurmi et al., 2008). Based on this, 
rye has been hypothesized to reduce risk of breast cancer  (Adlercreutz, 2010).  
1.2 Estimation of whole grain intake  
In observational studies, whole grain intake is typically estimated by self-
reporting methods such as food frequency questionnaires (FFQ) and dietary 
recalls, whereas food records are typically used in dietary intervention studies 
(Thompson and Subar, 2008). These methods are prone to relatively large 
measurement errors, particularly FFQs, which are typically used to estimate 
long-term whole grain intake (Kipnis et al., 2002, Kristal et al., 2005). The 
measurement errors are both random and systematic, and result from  
misreporting, poor information from databases on whole grain products, 
variations in the whole grain content in different whole grain products, and 
intake variation over time (Willett, 2012). In questionnaires, typically only a few 
questions can be used to capture whole grain intake, and the questions may cover 
foods that are typically based on several grains. Moreover, it is difficult to 
estimate whole grain intake from different grains separately by the dietary 
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assessment methods, which might be one major reason why so few observational 
studies have been conducted on the separate role of different whole grains, while 
dietary intervention studies to date have generally used whole grains foods based 
on mixed grains (Brownlee et al., 2010, Kristensen et al., 2012, Tighe et al., 
2010).  
   To overcome some of these obstacles and facilitate investigation of the role of 
different whole grain types in health, dietary biomarkers that provide objective 
measurement of specific whole grain intakes may be used (Landberg et al., 
2014). Alkylresorcinols in plasma and their metabolites in plasma and urine have 
been suggested, evaluated, and applied as concentration biomarkers of whole 
grain wheat and rye intake (Ross, 2012).  
1.3 Alkylresorcinols in cereals 
Whole grain wheat, rye, barley (Kulawinek et al., 2008, Ross et al., 2003c), and 
quinoa (Ross et al., 2017a) contain 5n-alkylresorcnols, which are a group of 
amphiphilic phenolic lipids. In whole grains, alkylresorcinols (AR) content is 
highest in rye (720-761 µg/g) (Nyström et al., 2008, Ross et al., 2003c) and 
common wheat (410-761 µg/g ) (Andersson et al., 2008a, Ross et al., 2003c), 
and significantly lower in barley (30-103 µg/g) (Andersson et al., 2008b, Ross 
et al., 2003c) and quinoa (32-93 µg/g) (Ross et al., 2017a). The main AR 
homologs present in wheat and rye consist of alkyl chains with odd number 
carbon atoms (C15:0, C17:0, C19:0, C21:0, C23:0 and C25:0) (Figure 1) 
(Kulawinek et al., 2008, Ross et al., 2003c) and are located in the outer part of 
the kernel (outer cuticula of the testa) (Landberg et al., 2008b). Recently, quinoa 
has been found to contain AR with even number carbon atoms chain or branched 
alkyl tails (Ross et al., 2017a). Unsaturated or keto/hydroxyl group substituted 
alkyl tails are also present in minor amounts in wheat and rye (Knödler et al., 
2010, Kozubek and Tyman, 1995, Kozubek and Tyman, 1999, Seitz, 1992, 
Wieringa, 1967). 
   During milling, AR are mainly found in the bran fraction, leaving very low 
amounts in the starchy endosperm and germ (Kulawinek et al., 2008, Landberg 
et al., 2008b, Ross et al., 2003c). For this reason, bran and whole grain wheat 
and rye products are the main sources of AR in the Nordic population, while 
refined wheat only provides a minor contribution. The AR content in different 
whole grain kernels is influenced by the plant species, thousand-grain weight 
(usually a negative correlation), breeding, growth environment, and extraction 
ratio in milling (Andersson et al., 2008b, Ross et al., 2003c, Shewry et al., 2010). 
AR are stable and can resist common food processing method, as shown by good 
correlations between the whole grain content in different food product 
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ingredients and final products (Chen et al., 2004, Landberg et al., 2006a, Menzel 
et al., 2012, Ross et al., 2003c).  
 
 
 
 Figure 1. Most common whole grain wheat and rye derived alkylresorcinols with odd number 
carbon atoms alkyl chains from C17:0 to C25:0. Modified from (Landberg et al., 2014).  
 
 
   The relative homolog composition of AR varies between grains, but 
remarkably little within grain species (Andersson et al., 2008a, Ross et al., 
2017a, Shewry et al., 2010). AR with both even and odd number carbon atoms 
alkyl chain are present in quinoa (Ross et al., 2017a), while the alkyl chains of 
AR found in rye and wheat only consist of odd number carbon atoms (Andersson 
et al., 2008a, Shewry et al., 2010). The AR C17:0/C21:0 ratio has been shown 
to differ between grains, with a ratio of 0.1 in whole grain wheat, 1.0 in whole 
grain rye, and 0.01 in durum wheat (Chen et al., 2004, Menzel et al., 2012, Ross 
et al., 2003c).  
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1.4 Absorption, distribution, and elimination of 
alkylresorcinols 
1.4.1 Absorption  
The absorption of AR was first studied in rats and about 50-65% of AR was found 
to be absorbed (Tłuscik et al., 1990). Ross and co-workers showed in an ileostomy 
operated pig model that AR are absorbed in the upper part of the gastrointestinal 
tract, with about 60-80% of the ingested dose absorbed (Ross et al., 2003b) and that 
about 60% was absorbed in 10 ileostomy operated subjects (Ross et al., 2003a).  
   In common with other lipophilic compounds, AR are not soluble in blood and 
therefore cannot be easily injected and therefore the absolute bioavailability has not 
been determined (Landberg et al., 2006b). However, higher relative bioavailability 
for longer AR homologs was suggested based on differences in dose-adjusted areas 
under the plasma concentration-time profiles for different homologs (Landberg et 
al., 2006b). 
1.4.2 Distribution  
After absorption in the small intestine, AR are transported to the systemic circulation 
either through the lymphatic pathway or portal vein (Linko-Parvinen et al., 2007, 
Marklund et al., 2014b). There is reported no differences in portal vein blood and 
arterial blood AR concentrations, suggesting that lymphatic absorption is the main 
route (Landberg et al., 2006b). Studies in pigs have confirmed the presence of AR 
in lymph (Marklund et al., 2014b). AR can be found in different blood fractions, 
mainly erythrocyte membranes and isolated lipoprotein fractions from plasma (very-
low-density lipoprotein and high-density lipoprotein). AR concentrations in 
erythrocyte membranes and lipoprotein are highly correlated, and higher proportions 
of longer AR homologs are incorporated into erythrocyte membranes (Linko-
Parvinen et al., 2007, Linko and Adlercreutz, 2005).  
   AR are also distributed in adipose tissue, as first indicated by radio activity 
measured in adipose tissue of rats fed a 14C-labeled C21:0 (Ross et al., 2004c) and 
later in a study where AR were measured in human adipose tissue biopsies (Jansson 
et al., 2010). However, the distribution of AR between blood and adipose tissue has 
not been studied in detail.  
1.4.3 Elimination  
Radioactive compounds detected in urine from rats fed 14C-labeled AR C21:0 (Ross 
et al., 2003b) have been identified as two main AR metabolites: 3,5-
dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (Ross et al., 
2004a, Ross et al., 2004b, Ross et al., 2004d). A rat feeding experiment has also 
shown that co-ingestion of AR elevates the γ-tocopherol level in liver and lungs 
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(Ross et al., 2004c), suggesting competition for metabolic enzymes, and thus, that 
AR might have similar metabolism to tocopherol (Birringer et al., 2001). Thus, it 
has been hypothesized that the alkyl chain in the AR molecule first undergoes ω-
oxidation, followed by β-oxidation to form 3,5-dihydroxybenzoic acid and 3-(3,5-
dihydroxyphenyl)-1-propanoic acid, which partly undergo phase II metabolism to 
form glucuronide and sulfate conjugates (Koskela et al., 2007). Several recently 
reported new metabolites of AR, including 2-(3,5-dihydroxybenzamido) acetic acid 
and 5-(3,5-dihydroxyphenyl) pentanoic acid and their glucuronide and sulfate 
conjugates, further support this hypothesis (Zhu et al., 2013). In addition, 3,5-
dihydroxycinnamic acid has also been found to be a metabolite of AR from rye 
foods, but it might not come from AR through the route mentioned above (Bondia-
Pons et al., 2013). AR metabolites are mainly excreted in urine (Marklund et al., 
2013, Ross et al., 2004a, Ross et al., 2004b, Ross et al., 2004d), but some have also 
been found in bile from pigs and ileostomal effluent from humans (Marklund et al., 
2014b). 
   The apparent elimination half-life of AR in plasma is estimated to be 4-5 h 
(Landberg et al., 2006b, Landberg et al., 2009a, Marklund et al., 2014b) whereas the 
half-life of the two main AR metabolites (3,5-dihydroxybenzoic acid and 3-(3,5-
dihydroxyphenyl)-1-propanoic acid) in plasma was somewhat longer (10.1-16.3 h) 
(Söderholm et al., 2009) and in urine (9.9-13.5 h) (Söderholm et al., 2011). Thus, 
AR in plasma and their metabolites in plasma and urine may only reflect short-term 
whole grain intake, particularly in populations with low and irregular intake. More 
long-term biomarkers are therefore highly warranted. 
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1.5 Alkylresorcinols and their metabolites as dietary 
biomarkers  
1.5.1 Dietary biomarkers 
Biomarkers can be defined in several ways. The National Institutes of Health 
defines a biomarker as “a characteristic that is objectively measured and 
evaluated as an indicator of normal biological processes, pathogenic processes, 
or pharmacologic responses to a therapeutic intervention.” (Strimbu and Tavel, 
2010). Biomarkers can be classified into three categories: exposure biomarkers, 
susceptibility biomarkers and effect biomarkers (Council, 1987). Exposure 
biomarkers should objectively reflect the xenobiotic material presented to an 
organism. Such a xenobiotic material can be a dietary component related to a 
specific food item. In nutritional studies, several biomarkers have been evaluated 
as indicators of food exposure and/or nutritional status (Bowman et al., 2011, 
Eisert et al., 2005, Lampe, 2003, Prentice et al., 2002, Yin et al., 2015). These 
biomarkers are referred to as dietary biomarkers, and can either represent the 
actual concentration or content of the nutrient or bioactive compound of interest, 
its metabolites, or its related metabolites in various biospecimen (Rappaport et 
al., 2014).  
 
Biomarker classification   
Dietary biomarkers can be classified as recovery biomarkers, concentration 
biomarkers, replacement biomarkers, and predictive biomarkers (Corella and 
Ordovas, 2015, Van Dam and Hunter, 2013).  
   Recovery biomarkers aim to provide unbiased estimates of the intake over a 
given period of time based on the concept of the balance of intake and excretion 
(recovery usually>80%) without being significantly influenced by differences in 
absorption, distribution, metabolism, and excretion (Bingham, 2002). 
Unfortunately, there are only a few biomarkers that qualify for this group, 
including doubly labeled water for average energy expenditure, and 24-h urinary 
nitrogen, sodium, and potassium for intake of protein, sodium, and potassium, 
respectively (Freedman et al., 2014, Kawasaki et al., 1993, Schoeller and van 
Santen, 1982, Schoeller et al., 1986).  
   Concentration biomarkers on another hand, reflect the concentration of target 
compound at a specific time point. Concentration biomarkers are affected not 
only by the dietary intake, but also by non-dietary determinants causing 
variations in absorption, distribution, metabolism, and excretion of the 
biomarker (Van Dam and Hunter, 2013). For example, vitamin C concentration 
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in serum has been used as a biomarker of vegetable and fruit intake (Drewnowski 
et al., 1997). However, the concentration of vitamin C is also affected by the 
smoking status of participant (Schectman et al., 1989).  
   Some concentration biomarkers for compounds with a poor or even no intake 
database have been classified as replacement biomarkers. The best example of 
replacement biomarkers are phytoestrogen concentrations in serum and urine as 
dietary biomarker of phytoestrogen intake (Grace et al., 2004).  
   Predictive biomarkers, share commonalities with recovery biomarkers but are 
recovered to a far lower extent (Tasevska et al., 2005). For example, sucrose and 
fructose in 24-h urine reflect and predict sugar consumption in subjects with less 
influence by factors other than intake than for concentration biomarkers but with 
a low recovery (< 0.1% of ingested dose) (Tasevska et al., 2005). 
 
Biomarker evaluation  
Any suggested dietary biomarker must be thoroughly evaluated (Bearer et al., 
2004). Validity and reproducibility of a dietary biomarker are two important 
features in determining biomarker performance. The validity of a dietary 
biomarker refers to its sensitivity and specificity in response to true dietary 
intake, i.e., the degree to which the biomarker measure what it is supposed to 
measure (Hunter et al., 2010, Kaaks, 1997). As there are no method that can 
measure diet without any measurement error (i.e., the true intake), repeated 
weighed food records have often been used as a proxy for true intake for 
biomarker validation (Eysteinsdottir et al., 2012, Kaaks, 1997). While 
comparing the biomarker with intake from FFQ, weaker correlations are 
typically observed as a result of relatively larger measurement error inherent in 
FFQ compared to food records. Correlations between an imperfect measure of 
dietary intake (due to measurement errors) and the biomarker reflect ‘relative’ 
validity (Masson et al., 2007, Ocke et al., 1997). 
   Since specific food intake varies over time, different numbers of repeated 
assessments are needed to capture the long-term mean intake of specific 
foods/nutrients (Fung et al., 2008). The reproducibility describes the correlation 
between repeated measurements within the same individual, i.e., the degree of 
fluctuation of the biomarker over time within an individual (Kaaks, 1997). This 
is often assessed by determination of the intra-class correlation coefficient (ICC) 
(Bartko, 1966), calculated as: 
 
ܫܥܥ ൌ ߪ஻ଶ ሺߪ஻ଶ ൅ ߪ௪ଶሻ⁄  
 
Where ߪ஻ଶ and ߪ௪ଶ  are inter- and intra-individual variation, respectively. 
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   The ICC is an estimate of the proportion of total variation that is due to 
variation between individuals. In other words, a high ICC indicates a small 
variation within an individual in relation to the variation between individuals, 
and thus a single measurement of the dietary biomarker is sufficient to reflect 
long-term food intake, which is often of primary interest in epidemiological 
studies (Hankinson et al., 1995).  
1.5.2 Alkylresorcinols in plasma and their metabolites in plasma or 
urine as intake biomarkers  
AR concentrations in plasma and the concentrations of their main metabolites 
(3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid) in 
urine have been evaluated as concentration biomarkers in several intervention 
and observational studies (Andersson et al., 2011, Cuff et al., 2015, Landberg et 
al., 2009a, Marklund et al., 2013, McKeown et al., 2016a, McKeown et al., 
2016b, Nybacka et al., 2016). The correlations between intake of whole grain or 
cereal fiber (as a surrogate) and plasma total AR concentrations were strongest 
(r=0.34-0.58) in studies using instruments with smaller measurement errors, e.g., 
weighed food records and FFQ specifically designed to capture whole grain 
intake, and weaker in studies with general FFQs (r=0.12-0.44) (Table 5).  
   Although the apparent half-life of plasma AR is relatively short, it reflected the 
whole grain intake and source of whole grain (wheat or rye) in populations with 
high and regular intake (Andersson et al., 2011, Landberg et al., 2013, Montonen 
et al., 2010). It has also been used in studies of different endpoints (Biskup et 
al., 2016, McKeown et al., 2016a, Olsen et al., 2010). Moreover, plasma AR 
concentration has been used to assess compliance in several whole grain 
intervention studies (Kristensen et al., 2012, Ross et al., 2011). A recent whole 
grain intervention study used plasma AR concentration to monitor the 
compliance of participants and observed that >60% of participants in the whole 
grain group did not follow the study design (Kristensen et al., 2017). Another 
study used AR concentrations along with other biomarkers as the basis to remove 
subjects with poor compliance in a secondary analysis of the outcome of a 
lifestyle intervention, and found significant improvements in the effects 
observed (Marklund et al., 2014a).  
   A main advantage of using intact plasma AR as biomarkers compared to their 
metabolites is the possibility to reflect total whole grain wheat and rye intake by 
measuring total AR concentration, but also the possibility to assess the relative 
intake of whole grain rye and wheat through measuring the AR C17:0/C21:0 
ratio (Kristensen et al., 2012, Kyrø et al., 2014a, Linko-Parvinen et al., 2007, 
Magnusdottir et al., 2014a). The plasma AR C17:0/C21:0 ratio has been shown 
to be lowest (around 0.1) in the UK with mainly wheat as the source of whole 
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grain intake (Kyrø et al., 2014a, Mann et al., 2015, Ross et al., 2007), modest 
(around 0.3) in Sweden and Denmark, where both whole grain wheat and rye are 
consumed (Kyrø et al., 2013, Kyrø et al., 2014a, Ross et al., 2007), and highest 
(around 0.6) in Finland, with relatively high consumption of whole grain rye 
(Kyrø et al., 2014a, Montonen et al., 2003). 
 
Table 5. Correlation of total plasma alkylresorcinol (AR) concentration with whole grain/cereal 
fiber intake from food frequency questionnaires (FFQ) and food records. 
1 Cereal-specific FFQ with 43-item on cereal products. 
 
   Beside AR concentrations in plasma, AR metabolites in plasma (Aubertin-
Leheudre et al., 2009, Aubertin-Leheudre et al., 2010), spot urine (Wierzbicka 
et al., 2017), 12-h urine (Guyman et al., 2008), 24-h urine (Landberg et al., 
2009a, Marklund et al., 2013) and 72-h urine have also been studied as 
biomarkers of whole grain intake (Aubertin-Leheudre et al., 2008, Aubertin-
Leheudre et al., 2010). AR metabolites in these matrices show a similar 
correlation to whole grain intake as intact AR in plasma and similar 
reproducibility (Cuff et al., 2015), but slightly longer half-life (~10h) 
Region  n  Intake variable  Method  Correlation  Reference 
Sweden  28  Whole grain intake 
3‐d weighed 
food records 
Spearman's 
r=0.58  (Landberg et al., 2008a) 
Sweden  51  Whole grain intake 
3‐d weighed 
food records 
Spearman's 
r=0.38  (Andersson et al., 2011) 
Finland  39  Rye bread  4‐d Food records 
Spearman's 
r=0.34  (Linko et al., 2005) 
Finland  56  Cereal fiber  3‐d Food records 
Pearson's 
r=0.41 
(Aubertin-Leheudre et 
al., 2008b) 
 
 
Switzerland 
 
 
29 
Whole grain 
intake 
3‐d weighed 
food records 
Pearson's 
r=0.57 
(Ross et al., 2009) 
Whole grain 
intake 
Cereal‐
specific FFQ1 
Pearson's 
r=0.54 
Denmark  360 
Rye bread  FFQ  Spearman's r=0.25 
(Landberg et al., 2011) 
Crisp bread  FFQ  Spearman's r=0.12 
UK  252  Whole grain intake  FFQ 
Spearman's 
r=0.33‐0.44  (Ross et al., 2012) 
US  407  Whole grain wheat‐rich foods  FFQ 
Spearman's 
r=0.31  (Ma et al., 2012)  
29 
 
(Söderholm et al., 2011). However, AR metabolites cannot reflect the source of 
whole grain (wheat or rye). 
1.5.3 Alkylresorcinols in adipose tissue as long-term biomarkers? 
Since long-term dietary exposure is probably most relevant in studies of the role 
of whole grain in chronic disease prevention, biomarkers for long-term intake of 
separate whole grains are greatly needed, particularly for studies in populations 
with low and irregular intake of whole grain.  
   Lipophilic compounds, such as fatty acids, have a longer half-life in adipose 
tissue than in blood (Katan et al., 1997, Strawford et al., 2004) and have been 
used as long-term biomarkers of diet in several studies (Ito et al., 1991, Petrek 
et al., 1997, Schmidt et al., 2014). Inspired by this concept, total AR 
concentration in adipose tissue has been measured and shown to be well 
correlated (r=0.48) with long-term whole grain bread intake from FFQ in a small 
pilot study (Jansson et al., 2010). This suggested AR in adipose tissue has large 
potential to be used as long-term biomarker of whole grain wheat and rye intake 
as well as their relative intakes. Such biomarkers could be used to investigate the 
potential role of whole grain rye for cholesterol reduction as well as investigating 
the controversial role of whole grains, particularly rye, in prevention of breast 
cancer. However, the analytical method for AR in adipose tissue reported in the 
pilot study (Jansson et al., 2010) does not allow analysis with high precision nor 
high-throughput. Moreover, studies to evaluate AR in adipose tissue as long-
term biomarkers by investigating response to controlled intakes, correlations to 
estimated intakes by different dietary assessment methods and in different study 
settings were lacking before the initiation of the research in this thesis.  
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2 Aims of thesis 
The overall aims of this thesis were to evaluate if AR in adipose tissue could be 
used as long-term biomarkers of whole grain wheat and rye intake and to 
investigate whether these biomarkers, in parallel with whole grain intakes 
determined by food frequency questionnaires, are associated with blood lipid 
profiles and breast cancer incidence in the Nordic populations. The aims were 
addressed through the following objectives: 
 
1) Develop a robust, high-throughput, sensitive and affordable GC-MS method 
for determination of AR concentrations in a small volume (10-50mg) of 
adipose tissue biopsy sample (Paper I).  
 
2) Investigate the response of AR concentrations in adipose tissue during 
controlled dietary intervention conditions using samples and data from a 12-
week whole grain intervention study (Paper II). 
 
3) Examine potential determinants of AR concentrations in adipose tissue 
among free-living men and women (Paper III). 
 
4) Compare the performance of AR concentrations in adipose tissue and in 
plasma as biomarkers of whole grain wheat and rye intake (Papers II-III). 
 
5) Investigate whether long-term intake of whole grain rye and/or wheat are 
associated with favorable blood lipid profiles, using FFQ-based estimates of 
whole grain intake, total AR concentrations and AR C17:0/C21:0 ratio in 
adipose tissue and plasma as exposure measurements (Paper IV). 
 
6) Investigate whether AR in adipose tissue, as biomarkers of whole grain rye 
and/or wheat, are associated with risk of developing breast cancer in a case-
subcohort study in Danish women (Paper V). 
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3 Materials and methods 
3.1 Reference compounds 
Analyzed alkylresorcinols (C17:0, C19:0, C21:0, C23:0 and C25:0) and AR used 
as internal standards (C20:0, C22:0, C24:0, C26:0) were of >95% purity and 
were provided by Reseachem Lifescience (Burgdorf, Switzerland). Similar 
weight of analyzed AR homologs were solubilized in methanol and diluted with 
methanol to nine different concentrations that reflected the range of AR likely to 
be found in plasma and in adipose tissue biopsy samples (Table 6). 
Alkylresorcinol internal standards (C20:0, C22:0, C24:0, C26:0) were 
solubilized in methanol (300 µg/L for each internal standard AR homologue) 
and used for preparation of calibration curves and in samples. 
3.2 Instrumentation 
AR in samples were quantified using two gas chromatography-single quadrupole 
mass spectrometry (GC-MS) instruments (Finnigan Trace GC/Finnigan Trace 
DSQ II, Thermo Fisher Scientific, Waltham, MA, USA). A stainless steel liner 
was installed in the spilt/splitless inlet on one of the GC-MS, while a straight 
glass liner was installed in the other GC-MS. ZB-5MS columns 
(15m×0.25mm×0.25µm, Zebron) were installed on both instruments. Helium 
(1.0mL/min) was used as carrier gas. 
3.3 Alkylresorcinols analysis in adipose tissue and 
plasma 
In the study described in Paper I, a method for quantification of AR in adipose 
tissue biopsies was developed and evaluated based on a method for AR 
measurement in plasma (Landberg et al., 2009b). The method comprises four 
main steps: (1) Sample extraction; (2) Solid phase extraction (SPE) clean-up; (3) 
Derivatization, and (4) GC-MS analysis.  
32 
 
 
 
 
 
Table 6. Standard solutions for calibration (n=9) and their corresponding target alkylresorcinol (AR) concentration in plasma or content in adipose tissue. 
Standard 
mixture 
   C17:0     C19:0     C21:0     C23:0     C25:0 
   nmol/L1  pmol/g2     nmol/L1  pmol/g2     nmol/L1  pmol/g2     nmol/L1  pmol/g2     nmol/L1  pmol/g2 
1 
 
3.5  14.0  2.5  10.0  2.8  11.2  2.3  9.2  2.2  8.8 
2 
 
7.0  28.0  5.0  20.0  5.5  22.0  4.5  18.0  4.4  17.6 
3 
 
20.9  83.6  15.0  60.0  16.6  66.4  13.6  54.4  13.2  52.8 
4 
 
34.8  139.2  25.0  100.0  27.7  110.8  22.6  90.4  22  88.0 
5 
 
69.5  278.0  50.0  200.0  55.4  221.6  45.3  181.2  43.9  175.6 
6 
 
104.3  417.2  75.0  300.0  83.2  332.8  67.9  271.6  65.9  263.6 
7 
 
208.6  834.4  150.0  600.0  166.3  665.2  135.8  543.2  131.7  526.8 
8 
 
347.7  1390.8  250.0  1000.0  277.2  1108.8  226.3  905.2  219.6  878.4 
9     417.2  1668.8     300.0  1200.0     332.7  1330.8     271.5  1086.0     263.5  1054.0 
 
1 Corresponding AR concentration in plasma if the standard mixture would have been spiked to 200 µL blank plasma. 
2 Corresponding AR concentration in adipose tissue sample if the standard mixture would have been spiked to 50 mg blank adipose tissue sample. 
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3.3.1 Sample extraction  
Plasma sample extraction  
Plasma (200 µL) was vortexed with internal standard (18.0 ng of AR in 15 μL 
methanol, which contained equal weight of AR C20:0, AR C22:0, AR C24:0, 
AR C26:0), and extracted with diethyl ether (3 mL), for a total of three times. 
The organic extract was combined and dried at 35 °C under a gentle stream of 
nitrogen in a glass test tube. Extracted AR in the dried glass tube were 
reconstituted in methanol (1 mL), ready for SPE clean-up (Landberg et al., 
2009b). 
 
Adipose tissue extraction 
Adipose tissue (10-50 mg) was homogenized using a bead homogenizer with 
internal standard solution (18.0 ng of AR in 15 μL methanol, which contained 
equal weight of AR C20:0, AR C22:0, AR C24:0, AR C26:0) and organic solvent 
A was added (1 mL of diethyl ether, methanol, or acetone was tested). The 
organic extract was transferred to a new tube and evaporated to dryness at 35 °C. 
The dried extract was then further extracted with organic solvent B (1 mL of 
diethyl ether, methanol or acetone was tested). Organic extract from the second 
extraction were either cooled at 4 °C for 30 min followed by filtration with a 
0.45 μm syringe filter, or centrifuged (0 °C, 20 817× g, 10 min). The clear 
extract/supernatant was ready for SPE clean-up.  
3.3.2 Solid phase extraction clean-up  
SPE-cleanup of plasma and adipose tissue was performed using either a four-
channel SPE robot (flow rate:1mL/min) with Oasis® MAX 60 mg SPE cartridges 
(Waters, Milford, MA, USA) or an 8-channel pipette with Oasis® MAX 96-well 
60 mg SPE plate (under 5 mm Hg). 
   The MAX cartridges were activated with 1mL of conditioning solution (0.1 M 
NaOH : methanol, 3:7 v/v), loaded with the clear sample extract, washed with 
methanol (3 mL), and finally eluted with 3 mL 2% formic acid in methanol 
(Figure 2). The eluted samples were evaporated to dryness under a nitrogen 
stream at 60 °C. 
   The same protocol as for MAX cartridges was applied to the MAX 96-well 
SPE plate, except that 4 mL instead of 3mL of 2% formic acid in methanol was 
used to elute AR from the plate during method development.  
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Figure 2. Sample cleanup with Oasis® MAX solid phase extraction cartridges. The MAX 
cartridges/plates were first activated with 1 mL of conditioning solution (0.1 M NaOH: methanol, 
3:7 v/v), and then sample contained unwanted matrix (yellow droplet) was loaded (A) and then 
cartridge was washed with 3 mL methanol (B). Unwanted matrix (yellow droplet) was eluted and 
discarded, while alkylresorcinols were retained on cartridge. Alkylresorcinols were eluted from the 
cartridge with 3 mL (or 4 mL during method development) 2% formic acid in methanol (C).  
 
 
3.3.3 Derivatization 
AR from adipose tissue were derivatized with trifluoroacetic anhydride (TFAA), 
while for AR in plasma, TFAA was compared with quick silylation mixture 
(QSM, pyridine:hexamethyldisilazane:trimethylchlorosilane, 9:3:1 v/v/v). 
Reaction conditions for the TFAA derivatization, including reaction time (30-60 
min), temperature (30-60 °C), reconstitution method (vortexing and/or heating), 
and stability of derivatized samples were investigated.  
 
3.3.4 Analysis of alkylresorcinols on GC-MS 
Plasma samples derivatized with QSM were analyzed using the method 
previously described (Landberg et al., 2009b). Briefly, sample (1.5 µL) was 
injected into the GC-MS fitted with a straight glass liner (300 °C) in splitless 
mode. The oven temperature was held at 100°C (0-1 min), raised to 250 °C by 
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8.6 °C/min, then raised to 300°C by 40°C/min, and held at 300°C for 2 min. The 
transfer-line and ion source was held at 310 °C and 250°C, respectively. Selected 
ion monitoring (SIM) under electron-impact ionization (EI) at 70eV was used 
for quantification, with a quantification ion (in bold) and a confirmation ion for 
each AR homolog: m/z 492 and 268 for C17:0, m/z 520 and 268 for C19:0, m/z 
548 and 268 for C21:0, m/z 576 and 268 for C23:0, m/z 604 and 268 for C25:0, 
and m/z 520 and 268 for C20:0 (internal standard). 
   Plasma and adipose tissue samples derivatized with TFAA were injected into 
the GC-MS fitted with a stainless steel liner. The transfer-line and ion source 
was held at 310 °C and 250°C, respectively. The GC conditions, including inlet 
temperature (250-320 °C), and oven temperature were optimized. The EI (70eV) 
and negative-chemical-ionization (NCI) modes were tested and compared.   
3.3.5 Calibration 
Standard solutions (Table 6) were randomly analyzed along with all samples in 
each batch. Known AR concentrations were linearly regressed against the ratio 
of target-AR/ internal-standard-AR. AR C20:0 was used to calibrate all target 
AR (C17:0-C25:0) in plasma samples, while different internal standard AR 
homologs were used for different AR homologs in adipose tissue: C20:0 for 
C17:0 and C19:0, C22:0 for C21:0, and C24:0 for C23:0 and C25:0.   
3.3.6 Evaluation of the method  
The linearity of the GC-MS was evaluated using standard solutions (Table 6) 
which covered likely AR concentrations in the needle biopsy adipose samples 
(usually around 10-50 mg). The linearity of the method was tested using six 
adipose tissue samples (10.2-54.0 mg) from one pig homogenized with a random 
number of stainless steel beads (n=1-6). The theoretical limit of detection (LOD) 
and limit of quantification (LOQ) were taken as the AR concentrations where 
the signal to noise ratio was 3 and 10, respectively. The precision of the method 
was estimated by analyzing AR concentration in replicates of a quality control 
adipose tissue (n=4 per day, repeated 3 times during one week). The accuracy of 
the method was evaluated by spiking the quality control adipose tissue with three 
levels of AR mixtures (10 ng, 20 ng and 30 ng of total AR; equal mass for all 
target AR homologs).  
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3.4 Samples and study designs  
  
Populations and study design used for the human studies reported in Papers II -
V are summarized in Table 7 and short descriptions are provided below.  
3.4.1 Populations, subjects and samples  
SYSDIMET (Paper II) 
Data, plasma and adipose tissue biopsy samples were obtained from the Dietary 
Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism 
(SYSDIMET, ClinicalTrials.gov Identifier: NCT00573781) study conducted on 
Finnish participants (n=131) (de Mello et al., 2011). All participants were aged 
47-65 years, had impaired glucose metabolism (fasting plasma glucose 
concentration in the range 5.2-7.8 mmol/L and 2-h plasma glucose concentration 
in the range 7.8-11.0 mmol/L), and met at least two of the following criteria: 
body mass index (BMI) 26-39 kg/m2; waist circumference ≥ 88 cm in women 
and ≥ 102 cm in men; blood pressure ≥ 130/≥ 85 mm Hg or use of medication 
for hypertension; serum triglycerides ≥ 1.7 mmol/L; and high-density 
lipoprotein-cholesterol (HDL-C) <1.3 mmol/L in women and <1.0 mmol/L in 
men at baseline. During the 12-week intervention, all participants were randomly 
allocated to one of three dietary intervention groups: (1) A refined diet group 
(RDG) (n=45) consuming refined wheat products; (2) a healthy diet group 
(n=44) with high intake of whole grain, fatty fish, and blueberries; and (3) a 
whole grain-enriched diet group (n=42) with high intake of whole grain. 
Participants in the healthy diet group and the whole grain-enriched diet group 
were asked to replace their other habitual cereal products with products 
containing more than 50% of whole grain and to consume more than 35 g (weight 
before cooking) whole grain pasta per day. In addition, a daily portion of their 
habitual cereal product was permitted, and oat snack bars were provided (one a 
day on a voluntary basis).  
   Since the whole grain intake guideline was the same for the healthy diet group 
and the whole grain-enriched diet group, these two groups were merged to one 
whole grain diet group (WGDG) for the purpose of the study. In total, plasma 
and adipose tissue samples from 17 subjects in the WGDG group and 10 subjects 
in the RDG group, collected at baseline and at end of the study (week 12), were 
available for analysis. 
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Table 7. Design of human studies (Papers II- V) 1 (AR = alkylresorcinols, FFQs = food frequency questionnaires) 
Paper Main objective Country Subjects Age
2 
(years) 
BMI2 
(kg/m2) Type of study Self-reported method Biopsy 
II Evaluate AR as biomarkers Finland 27 
  
12 wk intervention with two 
treatment groups. Whole grain 
diet group3 (WGDG, n=17) and 
refined diet group (n=10) 
Whole grain intake estimated 
by 4 day food records before 
the intervention (week 0) and 
in week3, 7, and 11 of the 
intervention. 
Adipose and plasma 
collected at baseline 
and after 12-wk 
intervention 
III 
Evaluate AR as 
biomarkers 
Sweden 
149 men 87 (85, 88) 24.6       (22.6, 27.2) 
Cross-sectional study. Men were 
randomly selected from the 
Cohort of Swedish Men-Clinical; 
women were randomly selected 
from the Swedish Mammography 
Cohort-Clinical 
Men: whole grain intakes 
were reported using repeated 
FFQs in 1997, 2009 and 
2010. 
Adipose tissue and 
plasma collected in 
2010 
Evaluate AR as 
biomarkers 
109 
women 66 (60,71) 
24.3       
(23.0, 25.7) 
Women: whole grain intakes 
were reported using repeated 
FFQs in 1987, 1997 and 
2003. 
Adipose tissue and 
plasma collected in 
2003 
IV 
Associate whole 
grain and blood 
lipids 
Sweden 109 women 66 (60,71) 
24.3       
(23.0, 25.7) 
Cross-sectional study. Women 
were randomly selected from the 
Swedish Mammography Cohort-
Clinical 
Whole grain intakes were 
reported using by FFQ in 
2003. 
Adipose tissue and 
plasma collected in 
2003 
V 
Associate whole 
grain and breast 
cancer risk 
Denmark 1 347 women 61 (58, 65) 
24.6       
(22.5, 27.5) 
Case-subcohort study between 
01/01/2001 and 27/04/2006 
Whole grain intakes were 
reported using FFQ 
distributed once at entry 
(1993 and 1997). 
Adipose tissue 
collected in a single 
sample at entry (1993-
1997) 
1 Women in Papers III and IV are the same group of people.  
2 Median (25th percentile, 75th percentile). 
3 Participants from the healthy diet group and the whole grain-enriched diet group in SYSDIMET (de Mello et al., 2011) consumed similar amounts of whole grain, 
and were therefore merged to one whole grain diet group (WGDG) in Paper II.   
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Swedish Mammography Cohort and the Cohort of Swedish Men 
(Paper III and IV) 
Between 1987 and 1990, the Swedish Mammography Cohort (SMC) (Figure 3) 
was initiated by inviting 90 303 women, born between 1914 and 1948 and living 
in the counties of Västmanland and Uppsala, central Sweden, by sending a 
questionnaire concerning diet (67-food items), height, weight, education, and 
marital status (FFQ-87). The response rate was 74%. In 1997, all SMC 
participants (n=56 030) who were still living in Västmanland and Uppsala were 
mailed a more comprehensive questionnaire which also included questions on 
dietary supplements, physical activity and smoking status (FFQ-97) (Wolk et al., 
2006), and response rate was 70%. Between 2003 and 2009, SMC women (n=8 
311) living in Uppsala County were invited to join SMC-Clinical. These women 
were asked to fill out a 123-item FFQ (FFQ-03); undergo a health examination, 
including dual energy X-ray absorptiometry scan, registration of body weight, 
height, blood pressure, and waist and hip circumference; and adipose tissue 
biopsies, fasting blood- and urine samples were collected. The response rate was 
60%. 
   The Cohort of Swedish Men (COSM) (Larsson et al., 2005) was initiated in 
1997 by inviting men living in the counties of Västmanland and Örebro, central 
Sweden and born between 1918 and 1952 (Figure 3). A total of 48 850 men filled 
out a questionnaire (as the FFQ-97 in the SMC). One more food related 
questionnaire (FFQ-09) was sent to all COSM members (n=37 861) who still 
lived in the study area in 2009, to which the response rate was 78%. The COSM-
Clinical was started since 2010 (still ongoing), by inviting all COSM men still 
residing in Västmanland County in that year, to fill out a 132-item FFQ (FFQ-
10), undergo the same health examination as for SMC-Clinical, and collection 
of adipose tissue biopsies, fasting blood and urine samples.  
   In total, data, adipose tissue biopsies, and plasma samples were available for 
109 SMC-C and 149 COSM-C participants in Papers III and IV, respectively. 
Blood lipids of SMC-Clinical participants had been measured in a previous study 
and the data were available.  
 
Danish Diet, Cancer and Health Study (Paper V) 
The Danish “Diet, Cancer and Health” cohort (Tjønneland et al., 2007) was 
started between 1993 and 1997, by inviting 80 996 men and 79 729 women, aged 
50-64, born in Denmark, living in Copenhagen and Aarhus area and were not  
39 
 
 
Figure 3. The Swedish Mammography Cohort (SMC) between 1987 and 2009, and the Cohort of Swedish Men (COSM) between 1997 and 2013. Women 
(n=109) were randomly selected from the SMC Clinical sub-study responders for Paper III and IV; men (n=149) were randomly selected from the COSM 
Clinical sub-study responders for Paper III.
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registered with a previous diagnosis of cancer in the Danish Cancer Registry 
(Gjerstorff, 2011). A total number of 27 178 men and 29 875 women joined the 
cohort between 1993 and 1997. All participants were ask to fill out a 192-item 
FFQ prior to visiting one of two study centers. At the study centers, participants 
were asked to complete a lifestyle questionnaire concerning years in school, use 
of HRT, smoking status, menopause status, parity, age at menarche, age at first 
birth, age at menopause, and physical activity. In addition, anthropometric 
measurements, including weight, height, sitting height, and waist and hip 
circumference were performed. A blood sample, a spot urine sample and toenail 
clippings were collected from each participant. A needle biopsy of adipose tissue 
(35-50 mg) was taken from the buttock, frozen (-20 °C) within 2 hours of 
collection, and stored in liquid vapor (max.-150 °C). Vital status, migration, and 
disease development were followed up continuously. Breast cancer cases during 
the follow-up were identified by the Danish Breast Cancer Cooperative Group, 
the Danish Cancer Registry (Gjerstorff, 2011), and the Danish Pathology 
Register (Bjerregaard and Larsen, 2011).  
   Data and adipose tissue from women who were diagnosed with breast cancer 
between date of entry and December 2000 have been used in a previous study 
(Raaschou-Nielsen et al., 2005). A case-subcohort study (Witt et al., 2009) was 
conducted by following women for breast cancer from January 1, 2001 (new 
entry point) until date of cancer diagnosis, date of death, date of emigration, or April 
27, 2006 (chosen as end of follow-up), which ever came first. Adipose tissue 
samples from this sub-cohort study were available (Witt et al., 2009), and 
therefore the same study design was used with a few modifications. In brief, all 
invasive breast cancer cases (n=500) diagnosed between January 1, 2001 and 
April 27, 2006 and a sub-cohort of non-cases (n=1115) randomly selected from the 
entire cohort were included. After excluding participants with missing adipose 
tissue biopsies, a case group (n=414; 345 ER+, 56 ER-, and 13 ER status 
unknown) and a subcohort of 933 non-cases (none of whom developed breast 
cancer during follow-up) remained and were included in the analysis.  
3.4.2 Dietary assessment of whole grain intake  
SYSDIMET (Paper II) 
Four-day food records with consecutive pre-defined days including one weekend 
day were used to estimate food intake in week before the intervention (week 0) 
and during weeks 3, 7, and 11 of the intervention. Food and nutrients were 
calculated using Nutrica software (https://fineli.fi/fineli/fi). Whole grain intake 
during weeks 3, 7, and 11 were averaged as whole grain intake during the 
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intervention. Whole grain intake information was missing for 11 participants in 
the WGDG. 
 
SMC and COSM (Paper III and IV) 
FFQs (FFQ-87, FFQ-97, and FFQ-03 for SMC; FFQ-97, FFQ-09, and FFQ-10 
for COSM) (Figure 3) were used to collect data on average food intake 
frequencies during the previous year (Thomas et al., 2011, Wallin et al., 2014, 
Warensjö et al., 2011). Frequencies were converted to average food intake 
(g/day) by multiplying age-specific portion sizes (based on data from weighed 
food records in 159 men over 2 weeks and 213 women over 4 weeks distributed 
over one year). Average intake frequency of whole grain foods, including 
‘crispbread’, ‘white bread’, ‘whole-meal bread’, ‘porridge’, ‘muesli’, ‘pasta’, 
and ‘pancake’, was multiplied by the specific average content of total whole 
grain, whole grain rye, and whole grain wheat listed for the corresponding food 
categories in the Swedish national food composition database (Bergström et al., 
1991). The average daily intake (g/day), including total whole grain intake 
(TWG), whole grain rye intake (WGR), and whole grain wheat intake (WGW), 
for every FFQ was calculated. Total whole grain rye and wheat intake 
(WGR&W) was calculated as the sum of WGW and WGR. Relative whole grain 
rye intake (WGR%) was calculated as the ratio of WGR to WGR&W. Average 
whole grain intake from FFQs during years prior to adipose/plasma biopsy was 
calculated: for men as the mean of all three FFQs (FFQ-97, FFQ-09, and FFQ-
10) for 14 years prior to adipose tissue and plasma biopsy and the mean of FFQ-
09 and FFQ-10 for two years prior to biopsy; and for women as the mean of all 
three FFQs (FFQ-87, FFQ-97, and FFQ-03) for 17 years prior to biopsy, and the 
mean of FFQ-97 and FFQ-03 for 7 years prior to biopsy.  
 
Danish Diet, Cancer and Health Study (Paper V) 
FFQ-based estimates, including mean daily intake of total energy, whole grain 
rye, and whole grain wheat, were calculated using the approach described in 
previous studies (Egeberg et al., 2009, Haraldsdottir et al., 1994, Helnæs et al., 
2016, Kyrø et al., 2011, Overvad et al., 1991, Tjønneland et al., 1991, 
Tjønneland et al., 1992). Total whole grain rye and wheat intake (WGR&W) 
was calculated as the sum of WGW and WGR. Relative whole grain rye intake 
(WGR%) was calculated as the ratio of WGR and WGR&W. 
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3.5 Statistical analysis 
All statistical analyses were conducted using SAS 9.3/9.4 for Windows (SAS 
Institute Inc., Cary, NC, USA). Two-sided P<0.05 was defined as statistically 
significant. Methods and models used in different studies are summarized in 
Table 8 and briefly described below. 
 
Paper II 
Whole grain intake and AR concentrations in adipose tissue and plasma were 
tested either with Wilcoxon’s signed-rank test between week 0 and week 12 for 
each group, or with Mann-Whitney’s U-test between two treatment groups at 
week 0 and week 12. Correlations between whole grain intake and AR 
concentrations in adipose tissue or in plasma were assessed by Spearman’s rank 
correlation coefficient.  
 
Paper III 
Concentration biomarkers were found to be right-skewed and were therefore log-
transformed before statistical analysis. Spearman’s rank correlation coefficient 
was calculated for all correlations assessed. Analysis of variance (ANOVA) and 
ICC (calculated with %icc9 SAS macro) (Hertzmark and Spiegelman, 2010) 
were used to examine the differences between FFQ estimates and the 
reproducibility of FFQ-based whole grain intakes across repeated FFQs for both 
genders. Associations between energy-adjusted (residual method) whole grain 
intake (WGR and WGW) and total AR concentrations in adipose tissue or in 
plasma were further tested using two multiple linear regression models. In Model 
1, total energy intake and energy-adjusted WGW and WGR were set as 
predictors, while total AR concentration in adipose tissue or in plasma (log-
transform) was used as the outcome in separate models. In Model 2, sex (man or 
woman), age (as continuous variable), and BMI (as continuous variable) were 
added to Model 1 as covariates.  
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Table 8. Statistical methods, statistical procedures used in SAS, dependent and independent variables, and covariates used (AR=alkylresorcinols, FFQ=food 
frequency questionnaire). 
Paper Statistical Procedure (SAS) Dependent variables Independent variables Covariate 
 II 
NPAR1WAY 
CORR 
  
AR concentrations in adipose tissue and 
plasma at week 0 and after the 12‐wk 
intervention 
 
Whole grain intake at week 0 and 
during the 12‐wk intervention 
 
 
 III  
CORR
%ICC 
MEANS 
ANOVA 
GLM 
Women: AR concentration in adipose tissue 
and plasma collected in 2003 
Women: Whole grain intake from 
FFQ‐87, FFQ‐97 and FFQ‐03  Age, BMI1, 
and sex Men: AR concentration in adipose tissue 
and plasma collected in 2010 
Men: Whole grain intake from FFQ‐
97, FFQ‐09 and FFQ‐10 
   
 IV 
MEANS 
CORR 
GLM 
Blood lipids measured in 2003 
Whole grain intake from FFQ‐03,  
total AR concentration and AR 
C17:0/C21:0 ratio  in adipose tissue 
and plasma collected in 2003 
Age and BMI1 
   
 V 
MEANS  
FREQ 
CORR 
PHREG 
Breast cancer incidence 
Whole grain intake from FFQ at entry,  
total AR concentration and AR 
C17:0/C21:0 ratio  in adipose and 
collected at entry 
BMI1, education, parity, HRT2, 
physical activity, smoking, alcohol, 
menopause, 
age at first birth,  
age at first menstruation. 
1 Body mass index. 
2 Hormone replacement therapy. 
44 
 
Paper IV 
Total whole grain rye and wheat intake, and relative whole grain rye intake 
among female participants were assessed using three approaches (FFQ, AR in 
adipose tissue, and AR in plasma) in relation to blood lipids using three multiple 
linear models: 1) An FFQ-model where energy-adjusted WGR&W and WGR% 
were used as predictors; 2) an adipose-AR-model where total AR concentrations 
and AR17:0/C21:0 ratio in adipose tissue were used as predictors; and 3) a 
plasma-AR-model where total AR concentration and AR17:0/C21:0 in plasma 
were used as predictors. Blood lipids (TCHOL, LDL-C, HDL-C, and 
triglyceride) were log-transformed to improve normality and separately entered 
as dependent variables. Least-squares means and 95% confidence intervals of 
blood lipids were calculated across exposure tertiles using PROC GLM. 
Predictors were centered with the median of corresponding tertiles and entered 
into the models as continuous variables to calculate P-values for trend. Models 
were further adjusted for age and BMI (both entered as continuous variables). 
 
Paper V 
Spearman’s correlation coefficients between WGR&W and total AR 
concentration in adipose tissue, and between WGR% and AR C17:0/C21:0 ratio 
in adipose tissue, were calculated. The time-to-event hazard ratios (HR) of total 
breast cancer and of ER+ and ER- breast cancer were calculated using Cox’s 
partial likelihood (Cox, 1992). Age (in days) was used as the time scale in the 
models. Since the study followed a case-cohort design, the risk set for cases 
outside the subcohort were set to half a day before their time of event (Prentice, 
1986). Total whole grain rye and wheat intake, and relative whole grain rye 
intake were estimated using FFQ or AR in adipose tissue, and used as exposures.  
 
The following statistical models were evaluated: 
(1)Crude FFQ-model: Energy-adjusted WGR&W + WGR% + total energy intake.  
(2)Crude AR-model: Total AR concentration + AR C17:0/C21:0 ratio.  
 
Exposures in the FFQ-model and the AR-model were either categorized 
according to quartiles or specified as continuous variables, where a one-unit 
increase represented:10g/day of energy-adjusted WGR&W; 10% of WGR%;  1 
nmol/g of total AR concentration in adipose tissue; and 0.1 of AR C17:0/C21:0 
ratio in adipose tissue. The crude models were further adjusted for previously 
studied breast cancer risk factors, including BMI, education, parity, HRT, 
physical activity, smoking, alcohol, menopause status, and age at first birth/first 
period.  
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4 Results and discussion 
4.1  Determination of alkylresorcinols in adipose tissue  
The final method developed and evaluated in Paper I and used for analysis of 
AR in adipose tissue and plasma in Paper III-V is shown in Figure 4. The results 
from method development and evaluation are summarized and discussed below. 
4.1.1 Sample extraction 
For sample extraction, a bead mill homogenizer was compared with  Heidolph 
Diax 600 homogenizer used in a previous method (Jansson et al., 2010).With the 
bead mill homogenizer, up to 24 samples could be analyzed at a time and 
potential cross-contamination between samples could be avoided. Different 
combinations of solvents A and B were tested for extraction and the combination 
of diethyl ether (A) and methanol (B) was selected, because all other 
combinations resulted in co-elution of large amounts of yellowish, oil-like 
impurities (even after further SPE clean-up), which caused poor baseline and 
required frequent maintenance of the GC-MS instruments. To remove remaining 
oil-like impurities extracted with the selected solvents, the sample extract was 
kept at 4 ºC for 30 min and impurities were crystalized and could be efficiently 
removed by filtration or centrifugation. Centrifugation was selected for the 
sample analysis in Paper V since it is cheaper than the filtration method and 
more robust. 
4.1.2 Solid phase extraction clean-up 
To increase throughput, an Oasis® MAX 96-well plate with 60 mg sorbent was 
tested and evaluated. Most of the applied AR (82.7-94.8%) were eluted from the 
96-well SPE plate during the first 1 mL of elution with 2% formic acid in 
methanol. Small amounts (<10%) of AR were found the second 1 mL of elution 
and the percentage was slightly higher for longer AR homologs, likely due to 
higher retention of longer AR homologues since Oasis® MAX also consists of 
hydrophobic interaction. Only small amounts of C17:0 (12.7%) and C21:0 
(5.5%) were lost during the washing step. In the final method, 3 mL of methanol 
was used during the SPE washing step to ensure the removal of matrix interfering 
compounds, while 3 mL of 2% formic acid in methanol elution were applied to 
the plate to ensure quantitative extraction of the AR applied. With the 96-well 
SPE plate, 92 unknown samples + 4 quality control samples could be purified  
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Figure 4. Final protocol for plasma and adipose tissue extraction, solid phase extraction, 
derivatization and GC-MS analysis. Steps or consumables underlined were introduced after the 
publication of Paper I. 
Plasma (200 µL) Adipose tissue (10-50 mg)
-Add 15 µL of internal standard  
-Add 1 mL of diethyl ether 
-6-7 stainless steel beads 
-Homogenize 
-Transfer the organic extract to a new tube 
-Evaporate to dryness at 35°C  
       under a gentle stream of nitrogen 
- Add1 mL of methanol to the dried extract 
- Vortex and keep at 4 °C for 30 min 
- Filter (0.45 μm)  
       Or centrifuge (0 °C, 20 817× g, for 10 min). 
 
Extract (1mL)
Eluted AR (3mL)
TFAA derivatizated AR in undecane (20 µL)
Oasis® MAX cartridge or 96-well plate
Conditioned 96-well Oasis® MAX cartridge or 96-well plates
-Wash with 3 mL methanol 
-Switch to a new plate collector 
-Elute with 3 mL of 2% formic acid in methanol   
×3 
Extraction 
Solid Phase Extraction 
D
erivatization 
Conditioned Oasis® MAX cartridge or 96-well plate
GC-MS analysis
- Add 15 µL of internal standard 
- Add 3 mL of diethyl ether 
- Vortex and freeze water phase  
        in a dry ice-ethanol bath 
- Pour the organic phase 
      into a new collection tube 
 
- Evaporate to dryness at 35°C 
   under a gentle stream of nitrogen 
- Add 1 mL of methanol 
-Evaporate to dryness at 60°C 
-Add trifluoroacetic anhydride: 
        300 µL for adipose tissue sample,  
    Or 200 µL for plasma sample 
-React at 40°C for 0.5 hour  
-Evaporate to dryness at 60°C  
-Add undecane (20µL)  
-Heat at 60°C for 20 min and vortex 
-Add 1 mL conditioning solution (0.1 M NaOH : methanol, 3:7v/v) 
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Figure 5. Total peak area percentage of alkylresorcinols homologs (C17:0-C25:0)) eluted from Oasis 
MAX solid phase extraction 96-well plate in three washing fractions using 1 mL methanol(ME01-ME03), 
followed by 4×1 mL elution fractions with 2% formic acid in methanol (FM01-FM04). 
 
within two hours, which is 3× faster than the method with an SPE robot used 
previously (Landberg et al., 2009b). 
4.1.3 Derivatization 
Derivatization of AR with TFAA was conducted at 40 °C. Excess TFAA could 
damage the GC column and metal liner, and was therefore removed after 
derivatization by evaporation at 60 °C. Reaction times longer than 30 min did not 
improve the yield of derivatized AR and therefore 30 min was selected. The GC-vial 
containing TFAA-derivatized AR in undecane were heated at 60 °C for 10 min and 
vortexed for 20s to ensure that AR compounds were dissolved, since the viscosity of 
undecane is relatively high and some remaining oil-like compounds in the sample 
after the SPE clean-up could interfere with the reconstitution of AR in undecane. This 
heat-vortex treatment significantly increased the precision of the analysis (Table 9). 
AR concentrations of the same batch of samples injected 2 week apart showed 
excellent agreement (r>0.99, P<0.001 for all target AR homologues). This shows 
good stability of the generated AR derivatized in undecane and samples could be 
stored for up to at least two weeks before analysis.  
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Table 9. Alkylresorcinols (AR) concentrations (nmol/g) determined in a quality control adipose tissue 
sample with and without heat-vortex treatment (60°C for 10min and vortex for 20s) after derivatization. 
(SD=standard deviation, CV=coefficient of variation) 
AR  
  Without heating (n=4)   With heating (n=4) 
 Mean  SD CV, %  Mean  SD CV, % 
C17:0  0.04 0.009 21.2  0.04 0.003 9.7 
C19:0  0.58 0.075 12.8  0.66 0.009 1.3 
C21:0  1.20 0.103 8.5  1.24 0.047 3.8 
C23:0  0.12 0.025 20.3  0.15 0.005 3.2 
C25:0  0.08 0.022 28.9  0.09 0.003 3.2 
Total    2.03 0.205 10.1   2.18 0.045 2.1 
 
4.1.4 GC-MS analysis and method evaluation 
Injection volume (2 µL) was a compromise between sufficient sensitivity, ensuring 
low contamination in the liner to keep longer maintenance intervals and possibilities 
for reinjection of samples. The chromatographic settings enabled good separation of 
all AR homologs in the standard mixture (Figure 5) and in adipose tissue and plasma 
samples. The TFAA-derivatized AR were scanned under EI (70eV) and NCI mode. 
The EI mode was selected since comparable sensitivity was found for EI and NCI, 
while the throughput was much higher for EI than for NCI due to more frequent 
instrument maintenance when the instrument was operated in this mode (data not 
shown).   
   In EI mode, molecular ions and a common base ion (m/z 316) found in all TFAA-
derivatized AR homologs were detected (Figure 6). Compared with molecular ions, 
the base ion had a higher signal to noise ratio, indicating good linearity (r2>0.99) 
across the concentrations of standard solutions. Based on these findings, the base-ion 
was selected for quantification with SIM mode. The theoretic LOD/LOQ per 
injection for AR were 0.04/0.12 fmol for C17:0, 0.05/0.16 fmol for C19:0, 0.02/0.08 
fmol for C21:0, 0.02/0.07 fmol for C23:0, and 0.09/0.31 fmol for C25:0. Inter- and 
intra- batch coefficient of variation (CV) and accuracy for plasma and adipose tissue 
samples were satisfactory for most homologues at different concentration ranges 
(Table 10). 
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Figure 6. Comparison between Scan (A) and selective ion monitoring (SIM) modes (A-H) of an 
alkylresorcinol mixture (C17:0-C25:0) analyzed in the scan mode (m/z 50-650) and the same sample 
analyzed with SIM mode. A. Total ion chromatogram (TIC), B. the common base ion m/z 316 for all AR 
homologues, C. molecular ions m/z 540 for C17:0, D. molecular ions m/z 568 for C19:0, F. molecular 
ions m/z 582 for C20:0, F. molecular ions m/z 596 for C21:0, G. molecular ions m/z 624 for C23:0, and 
H. molecular ions m/z 652 for C25:0.  
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Table 10. Intra- and inter-batch precision (as coefficient of variation) for determination of alkylresorcinols (AR) in an  adipose tissue  and a plasma sample 
used as  in-house quality controls (n=4 per batch, 3 batches in total) and recovery from spiking experiments (n=4 for each spiking level). (CV=coefficient of 
variation) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Spiked amount of each AR homologs was 2 ng for plasma samples and 0.4 ng for adipose tissue samples. 
2 Spiked amount of each AR homologs was 4 ng for plasma samples and 2 ng for adipose tissue samples. 
3 Spiked amount of each AR homologs was 6 ng for plasma samples and 6 ng for adipose tissue samples. 
 
AR in 
  
Average 
  Intra-batch 
CV (%) 
  Inter-batch 
CV (%)  
  Recovery, % 
        Low1   Median2   High3 
Adipose    pmol/g           
C17:0    5  13.7  16.4  109  95  102 
C19:0    31  4.4  8.3  88  89  90 
C21:0    87  3.5  11.3  61  81  92 
C23:0    53  4.4  14.2  81  82  88 
C25:0     89  4.1  12.0  105  109  95 
               
Plasma    nmol/L  
C17:0 5.7 3.3 5.9 110 109 110 
C19:0 17.2 1.8 8.5 97 91 118 
C21:0 18.8 2.6 12.4 90 94 110 
C23:0 6.6 3.2 2.6 83 76 98 
C25:0 7.0 7.5 8.8   99  106  101 
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4.2 Alkylresorcinols in adipose tissue in response to a 
12-week controlled whole grain intervention  
In Paper II, the response of AR concentrations in adipose tissue to controlled 
whole grain intake under intervention conditions for 12 weeks was evaluated for 
the first time. At baseline (week 0), there was no difference in whole grain intake 
between the groups (Figure 7). The estimated whole grain intake at baseline was 
in agreement with intakes for the general Finnish population reported in the 
National Findiet 2012 survey (Helldán et al., 2013). 
   During the 12 weeks intervention, WGDG group did not change its whole grain 
intake significantly compared with baseline, due to already high habitual whole 
grain intake at baseline, but RDG significantly reduced its whole grain intake 
during the RDG intervention.  
   The AR concentrations in plasma and adipose tissue were in the range reported 
previously for Nordic populations (Aubertin-Leheudre et al., 2008, Jansson et 
al., 2010, Kyrø et al., 2014a, Landberg et al., 2011, Magnusdottir et al., 2013). 
In accordance with the reported whole grain intake, AR in plasma or adipose 
tissue at baseline did not differ between the groups.  
 
Figure 7. Median and 25th -75th percentiles (error bars) of whole grain intake reported in the whole 
grain diet group (WGDG) and refined diet group (RDG) at week 0 and week 12. Wilcoxon signed-
rank test was used to compare each parameter within group between week 0 and week 12, and 
Mann–Whitney’s U-test for parameters between treatment groups. *P<0.05, **P<0.01 and 
***P<0.001. 
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Figure 8. Median and 25th -75th percentiles (error bars) of alkylresorcinol (AR) concentrations in 
plasma and adipose tissue at week 0 and week 12 among subjects in the whole grain diet group 
(WGDG) and refined diet group (RDG). Wilcoxon signed-rank test was used to compare each 
parameter within group between week 0 and week 12. *P<0.05, **P<0.01 and ***P<0.001. 
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   After the intervention, concentrations of all AR homologs in adipose tissue and 
plasma differed between treatments (Figure 8). This suggest that both plasma 
and adipose tissue reflected the reduction in whole grain intake in RDG during 
the12-week intervention.  
   Average whole grain intake from three 4-day food records (week 3, week 7 
and week 11) was strongly correlated with AR in adipose tissue (r=0.60-0.84, 
P<0.05) and in plasma (r=0.60-0.72, P<0.05) at week 12. However, there was 
no significant association between whole grain intake and AR in adipose tissue 
or in plasma at baseline, which might due to lack of precision in estimating whole 
grain intake at base-line, where subjects had their habitual diet.  
4.3 Alkylresorcinols in adipose tissue as biomarkers 
under free-living conditions  
4.3.1 Relative validity and determinants beyond intake 
 
Paper III  
In Paper III, the performance of AR in adipose tissue as biomarkers of long-
term whole grain intake was investigated among free-living Swedish men and 
women. At the time of adipose and plasma sampling, men were older than 
women, but BMI was similar between men and women. Adipose tissue from 
men contained a higher concentration of total AR than adipose tissue from 
women, while AR C17:0/C21:0 ratio in adipose tissue, total AR concentration, 
and AR C17:0/C21:0 ratio in plasma did not differ significantly between men 
and women.  
   The concentration of AR in adipose tissue was within the range reported 
previously for a few SMC participants (Jansson et al., 2010) and for Finnish men 
and women (Paper II)  
   Similar whole grain intake was reported in the three repeated FFQs among men 
over a period of 17 years (Figure 9). For women, significantly higher whole grain 
intakes (P<0.05) and lower energy intake (P<0.05) were reported in FFQ-87 
compared with the other FFQs, but no difference was found between FFQ-97 
and FFQ-03. 
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Figure 9. Median, 25th percentile, and 75th percentile of daily whole grain wheat (WGW) and whole 
grain rye (WGR) intake from food frequency questionnaires (FFQ) for women (in 1987, 1997 and 
2003) and men (in 1997, 2009 and 2010). Intra-class correlations (ICC) of WGW and WGR 
between the closest FFQ are also listed. *, intake variable significantly higher than the 
corresponding intake from other FFQ in the Student’s t-test for the same gender. 
 
Figure 10. Percentage change in total alkylresorcinol (AR) concentration in adipose tissue and 
plasma per 10 g/day increment in energy-adjusted (residual method) intake of whole-grain wheat 
(WGW) and whole-grain rye (WGR), per 1 Mcal/day increment in total energy intake , sex (female 
vs male), per 1 kg/m2 increment in body mass index (BMI), and per year increment in age among 
free living Swedish men (n=149) and women (n=109). Plasma samples were missing from 19 
women. Model 1 included intake of WGW and WGR, and total energy intake; Model 2 included 
intake of WGW and WGR, total energy intake, sex, body mass index (BMI), and age.   
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   The correlations between whole grain intakes and AR in adipose tissue were 
modest, with TWG (r=0.22-0.42) and WGR&W (r=0.27-0.44) were more strongly 
correlated to biomarkers than whole grain products intake (r=0.15-0.36), illustrating 
the advantages of deriving and using whole grain intakes (g/d) instead of product 
intake estimates in this population.  
   Correlation coefficients were strongest for WGR (r=0.31-0.42), weaker for 
WGR&W and TWG, and poor for WGW (r=0.09-0.33). This is most likely because 
WGR is mainly from crispbread which is consumed frequently and regularly 
(contributing 67-74% of WGR; ICC: 0.37-0.56); whereas the main sources of WGW 
are whole-meal bread and pasta (contributing 58-73% of WGW), which have larger 
variation in whole grain contents and are more irregularly consumed (ICC: 0.01-
0.28). Correlation coefficients for TWG reported and AR concentration in adipose 
tissue in this study were in agreement with those found previously in one small study 
in the same population where an FFQ was used (Jansson et al. 2010), but much 
weaker than when using whole grain intake estimated by food records (r=0.60-0.84) 
(Paper II). This suggests that FFQ-based whole grain intake values are more prone 
to measurement errors than values from food records. 
   Repeated FFQs could be used to improve precision in estimating long-term whole 
grain intake and thereby improve correlations, as shown in studies comparing 
estimated fatty acid intakes by repeated FFQs with corresponding fatty acids in 
erythrocytes (Sun et al., 2007). In Paper III, correlation coefficients between WGW 
or WGR and adipose tissue AR concentrations were stronger when the mean of 
repeated FFQs was used rather than estimates from a single FFQ, even when that 
FFQ was close in time to the biopsy. Correlations between WGR from repeated FFQs 
and biomarkers were improved to a lesser extent than for WGW, probably due to 
better precision in estimating long-term WGR intake. 
   Correlations between whole grain intake and biomarkers were stronger for women 
than men, suggesting that women had more stable whole grain intake than men and/or 
reported their intakes more accurately, despite longer time intervals between their 
repeated FFQs.  
   Among non-dietary determinants investigated, gender was found to be significantly 
associated with total AR concentration in adipose tissue (Figure 10). Adipose tissue 
total AR concentration was 61.3 % lower in women than in men after adjusting for 
energy-adjusted whole grain wheat and rye intake, BMI, and age.  
   Similarly, higher plasma AR concentrations have been found for men than women 
in several previous studies (Montonen et al., 2010, Ross et al., 2012) and the 
difference has been suggested to be due to faster elimination of AR in women than in 
men (Frank et al., 2008). Higher plasma AR concentrations among men than women 
are likely to lead to more extensive accumulation in adipose tissue in men. An 
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additional reason for lower adipose tissue AR concentration in women could be larger 
distribution volume in women due to higher body fat content among women than men 
(Ley et al., 1992). However, this cannot be confirmed since X-ray absorptiometry 
data were not available for the men studied in Paper III. In contrast to what has been 
shown for AR in plasma in other populations, there was no evidence of a difference 
in AR concentrations in adipose tissue (or in plasma) due to age.    
 
Paper V 
In Paper V, total AR concentration in adipose tissue of the Danish subjects was 
within the same range as observed among Swedish subjects in Paper III and as 
reported in a previous study (Jansson et al., 2010), but lower than in Finnish subjects 
(Paper II). This is in agreement with the whole grain intake reported in these three 
countries (Finland>Sweden=Denmark) (Kyrø et al., 2012, Nurmi et al., 2009). The 
AR C17:0/C21:0 ratio in adipose tissue from the Danish women in Paper V was 
lower than among Swedish subjects (Paper III). The slightly lower AR C17:0/C21:0 
ratio in adipose tissue is in contrast to the higher proportion of whole grain rye in the 
diet observed among the Danish women compared with Swedish participants in 
Paper III. In Paper V, total AR concentration in adipose tissue was modestly 
correlated with WGR&W (r=0.31, P<0.001), WGR (r=0.28, P<0.001) and WGW 
intake (r=0.16, P<0.001). The correlation coefficients were similar to those found for 
Swedish subjects (Paper III).  
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4.4 Alkylresorcinols in adipose tissue vs. alkylresorcinols in 
plasma as biomarkers 
Based on the results in Paper II, it appears that AR in adipose tissue have a much 
faster turnover rate than many other lipophilic compounds, such as fatty acids 
(Beynen et al., 1980, Handelman et al., 1994, Strawford et al., 2004).  Lipophilic 
compounds are typically stored in adipocyte cytoplasmic lipid droplets (Brasaemle, 
2007) but, in analogy with tocopherols, AR are known to associate in biological 
membranes (Asghar et al., 1991, Linko and Adlercreutz, 2005, Simon et al., 2001). 
We hypothesized that AR are incorporated into the membranes of adipocytes (Asghar 
et al., 1991, Linko and Adlercreutz, 2005, Simon et al., 2001) where the turnover rate 
is faster than for lipophilic compounds in adipocyte cytoplasmic lipid droplets 
(Beynen et al., 1980, Handelman et al., 1994, Strawford et al., 2004). The suggested 
rapid turnover rate of AR in adipose tissue may explain why they are well correlated 
with AR in plasma (r=0.40-0.71, P<0.05 for AR C17:0, C19:0, C23:0 and C25:0; 
r=0.27, P=0.17 for AR C21:0).  
   Initially, due to longer anticipated half-life of AR in adipose tissue than in plasma 
(Strawford et al., 2004), AR concentration in adipose tissue were expected to be 
better correlated to FFQ-based whole grain intakes than AR in plasma in Paper III. 
However, the correlations were of similar magnitude. One reason could be that AR 
in adipose tissue is located in the adipocyte membrane and that the turnover is rapid, 
as discussed above. Another reason could be that plasma AR concentration also 
reflected long-term whole grain intakes among the subjects in Paper II and III, as 
has been shown from populations where whole grain intake is frequent and regular 
(Andersson et al., 2011, Landberg et al., 2013, Montonen et al., 2010). Moreover, 
the large measurement error inherent in FFQ-based whole grain intakes might have 
masked any potential difference in correlations with AR in adipose tissue and plasma 
in Paper III. The fact that the strongest correlation between AR in adipose tissue and 
plasma was observed between short homologs and that AR concentrations in adipose 
tissue were more than 10-fold higher than in fasting plasma suggests that the AR 
concentration in fasting plasma may to a large extent derive from AR liberated back 
from adipose tissue, as has been shown for fatty acids in fasting plasma  (Halliwell et 
al., 1996). Mechanistic, controlled feeding studies needs to be conducted to clarify 
what mechanism that is at play. 
   Based on the results from Papers II-IV, it appears that AR concentrations in 
adipose tissue reflect long-term whole grain rye and wheat intake in a similar way as 
AR concentrations in plasma, in the populations investigated in this thesis. A clear 
advantage of using AR in adipose tissue biopsies instead of AR in plasma is that the 
former are not likely to be affected and potentially confounded by the lipoproteins 
that transport AR in plasma. On the other hand, adipose biopsy samples are less 
available from studies compared with plasma samples. 
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4.5  Alkylresorcinols in adipose tissue in relation to blood 
lipids 
The associations between whole grain wheat and rye intake estimated by FFQ or 
reflected by AR in adipose tissue or plasma with blood lipid concentrations were 
investigated using data and samples from women in Paper III. BMI and age did 
not significantly differ across tertiles of AR (T1-T3) in adipose tissue and in 
plasma. As mentioned earlier, AR concentrations in adipose tissue and plasma 
and the AR C17:0/C21:0 ratio in Paper III were similar to those reported in 
other Nordic studies with mixed consumption of whole grain wheat and rye 
(Andersson et al., 2011, Cuff et al., 2015, Jansson et al., 2010, Kyrø et al., 2014a, 
Landberg et al., 2009c, Marklund et al., 2013, Nybacka et al., 2016).  
   Total AR concentration in adipose tissue was inversely associated with 
TCHOL and HDL-C (P-trend<0.05) (Figure 11). Participants in T3 of total AR 
concentration in adipose tissue had 8.7% (95% CI: 1.3-15.4%) lower TCHOL 
and 13.5% (95% CI: 2.9-23.0%) lower HDL-C compared with participants in 
T1. These findings suggest that total intake of whole grain rye and wheat was 
associated with lower TCHOL, mainly driven by lower HDL-C concentrations. 
Separate roles of whole grain rye and whole grain wheat were investigated using 
AR C17:0/C21:0 ratio in adipose tissue (Figure 11). A higher ratio of AR 
C17:0/C21:0, reflecting higher relative whole grain rye intake, was associated 
with higher HDL-C and lower LDL-C (P-trend<0.05). Participants in T3 of the 
AR C17:0/C21:0 ratio in adipose tissue had a 14.2% (95%CI: 1.6-28.4%) higher 
HDL-C and a 13.9% (95% CI: 3.0-23.5%) lower LDL-C compared with 
participants in T1.  
   Based on the results for total AR concentration and AR C17:0/C21:0 ratio in 
adipose tissue, it appears that high total and relative whole grain wheat intake 
may explain the inverse association with HDL-C observed. The lower LDL-C 
associated with higher C17:0/C21:0 ratio is in agreement with a previous study, 
where this ratio in plasma was associated with lower LDL-C in men and women 
with signs of metabolic syndrome (Magnusdottir et al., 2014c).  
   We hypothesize that the beneficial association observed for whole grain rye, 
reflected by the C17:0/C21:0 ratio, is due to higher content of viscous dietary 
fiber (Buksa et al., 2016, Laerke et al., 2015, Pettersson and Åman, 1988) and 
phytosterols (Andersson et al., 2013, Nurmi et al., 2008) in rye than in wheat. 
Around 80% of the viscosity in rye has been attributed to water soluble 
arabinoxylans (Bengtsson et al., 1992). Although arabinoxylans can be found in 
both whole grain rye and whole grain wheat, the viscosity formed by 
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Figure 11. Percentage change and P-trend (*P<0.05, **P<0.01 and ***P<0.001) of total 
cholesterol, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol 
(LDL-C), and triglycerides (TG) across tertiles of total whole grain rye and wheat intake or relative 
whole grain rye intake derived from food frequency questionnaire (FFQ), alkylresorcinols (AR) in 
adipose tissue, or in plasma among free living Swedish women (n=109). Plasma samples were 
missing from 19 women. The multivariate models were adjusted for body mass index (BMI) and 
age. WGR&W= sum energy-adjusted intake of whole grain rye and whole grain wheat from FFQ; 
WGR%= the ratio of FFQ-based whole grain rye intake and WGR&W.  
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arabinoxylans in rye is more extensive and resistant to food processing 
(Johansson et al., 2017). Pigs fed rye have significantly higher viscosity of ileal 
digesta than pigs fed whole grain wheat (Laerke et al., 2015). The resistant 
viscosity formed by arabinoxylans from rye might lower LDL-C in the blood 
through similar mechanisms as beta-glucan from oats and barley (Wolever et al., 
2010). Future dietary interventions with different doses of rye foods rich in 
viscosity forming arabinoxylans should be conducted to test this hypothesis. 
4.6 Alkylresorcinols in adipose tissue in relation to breast 
cancer incidence 
In Paper V, there was no statistically significant association between WGR&W 
intake or AR concentration in adipose tissue and the risk of developing breast 
cancer (total, ER+, or ER-) (Figure 12). This is in agreement with findings from 
a prospective analysis based on the entire “Diet, Cancer and Health” cohort 
(Egeberg et al., 2009) and suggests that total whole grain rye and wheat intake 
has a limited preventive effect on associated breast cancer incidence among 
women in a population with high and diverse whole grain intake. This is 
supported by results from observational studies (Suzuki et al., 2008, Terry et al., 
2002, Zhang et al., 2011) which in general show no significant associations 
between cereal fiber intake and breast cancer. However, some bioactive 
compounds found in whole grain rye and wheat have been suggested to reduce 
breast cancer development (Adlercreutz, 2010, Jacobs et al., 1995, Slavin, 2000).  
   One of the most studied group of bioactive compounds in this aspect are the 
lignans (Adlercreutz et al., 1992, Adlercreutz et al., 1993, Adlercreutz, 1998, 
Adlercreutz, 2007, Andersson et al., 2013, Nilsson et al., 1997, Slavin, 2003). 
Plant lignans are metabolized by intestinal bacteria to the mammalian lignans 
enterodiol and enterolactone(Jacobs et al., 2007). Enterolactone has been 
suggested to reduce the risk of breast cancer by lowering the activity of estrogen 
(Adlercreutz et al., 1992, Adlercreutz et al., 1993, Adlercreutz, 1998, 
Adlercreutz, 2007), and has been found to be inversely associated with ER+ 
breast cancer, but to have no effect on ER- breast cancer, in tamoxifen prevention 
trials (Cuzick et al., 2003).  
   In a previous study with all Danish postmenopausal women from the same 
cohort as used in Paper V, an inverse association between circulating 
enterolactone concentrations and risk of developing breast cancer was found for 
ER-, but not ER+, breast cancer (Olsen et al., 2004). However, enterolactone is 
affected by several determinants other than whole grain wheat and rye, which 
may have contributed to the enterolactone concentrations associated with 
reduced ER- breast cancer risk in that study.  
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   Another reason for the lack of association between total whole grain wheat and 
rye intake and breast cancer could be differing roles of rye and wheat in 
modifying the risk of developing breast cancer.  
 
 
Figure 12. Association between total whole grain rye and wheat intake or relative whole grain rye 
intake and risk of developing invasive breast cancer (BC), estrogen-receptor-positive (ER+), or 
estrogen-receptor-positive (ER-). AR, alkylresorcinols; WGR&W= sum of energy adjusted intake 
of whole grain rye and whole grain wheat from FFQ; WGR%=ratio of FFQ-based whole grain rye 
intake to WGR&W. Hazard ratios (HR) and 95% Confidence intervals of breast cancer for quartiles 
of total whole grain rye and wheat intake (WGR&W or total AR concentration in adipose tissue), 
or relative whole grain rye intake (WGR% or AR C17:0/C21:0 ratio). HR for per unit of these 
exposures (10g/day for WGR&W; 10% for WGR%; 1nmol/L for total AR concentration; and 0.1 
for AR C17:0/C21:0 ratio) were also calculated. 
 
   In Paper V, a higher AR C17:0/C21:0 ratio in adipose tissue, which partly 
reflected a higher relative whole grain rye (or lower relative whole grain wheat) 
intake was consistently associated with an increased risk of ER+, but not ER- 
breast cancer (Figure 12). Although P-trends for WGR% did not reach statistical 
significance, women in the highest quartile of WGR% had around 55% higher 
risk of ER+ breast cancer than women in the lowest quartile. Higher AR 
17:0/C21:0 ratio in adipose tissue could reflect higher whole grain rye intake in 
the diet, but might also relate to as yet unknown dietary/non-dietary factors.  
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   A high intake of short AR homologs such as AR C17:0, which is mainly from 
whole grain rye (Chen et al., 2004, Menzel et al., 2012, Ross et al., 2003c) will 
result in a high C17:0/C21:0 ratio. Theoretically, the presence of C17:0 in 
adipose tissue of the breast may have promoted synthesis of progestogens and 
suppressed the downstream metabolism of progestogens and estradiol, as shown 
in vitro (Oskarsson and Ohlsson Andersson, 2016). High concentrations of these 
sex hormones are strongly associated with elevated risk of postmenopausal 
breast cancer (Key et al., 2002). In support of this theory, it was indicated in 
Paper V that high concentrations of AR C17:0, but not AR C19:0 or ARC21:0 
were associated with an increased risk of developing ER+ breast cancer (data not 
shown). Future intervention studies in animals and humans are needed to 
evaluate the potential role of AR on sex-hormone metabolism and the role of 
C17:0/C21:0 as a biomarker in relation to breast cancer. 
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5 General discussion 
Alkylresorcinols concentrations in plasma and the concentration of their 
metabolites in plasma and urine have been evaluated and increasingly used as 
dietary biomarkers in epidemiological and whole grain intervention studies 
(Biskup et al., 2016, Drake et al., 2013, Landberg et al., 2008a, Magnusdottir et 
al., 2013, Magnusdottir et al., 2014a, Magnusdottir et al., 2014b, McKeown et 
al., 2016b, Nybacka et al., 2016, Olsen et al., 2010, Ross et al., 2004d). 
However, due to the short half-life, their use may be limited to populations where 
the intake of whole grain is high and stable (Andersson et al., 2011, Landberg et 
al., 2013, McKeown et al., 2016a, Montonen et al., 2010). This PhD project was 
based on the hypothesis that this could be overcome by evaluating AR 
concentration in adipose tissue as more long-term biomarkers. AR were found 
to be present in adipose tissue of Swedish women in a small pilot project 
conducted before the start of this project and the concentrations were found to 
be correlated with estimated intake (Jansson et al., 2010). However, the 
responsiveness of AR in adipose tissue to controlled intake, factors affecting 
adipose tissue AR concentrations, and the performance of AR in adipose tissues 
as biomarkers and their relationship with disease endpoints had never been 
tested. 
   It took around two years and more than 10,000 sample injections to develop 
and evaluate the analytical method for analysis of AR in adipose tissue (Paper 
I). The GC-MS method developed can be used for both adipose tissue and 
plasma samples. Moreover the sensitivity is 10-to 40-fold higher and the method 
is 3 ×faster in running time, compared with the original method suggested for 
analysis of AR in plasma and adipose tissue (Jansson et al., 2010, Landberg et 
al., 2009b). Around 100 adipose tissue or plasma samples per day can be 
analyzed with the new method, which enabled large-scale validations and 
applications in the studies on which this thesis is based (Paper III-V) and in 
studies to come.  
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   Since a ‘gold standard’ for determination of whole grain intake is still lacking 
(Kaaks, 1997), in this thesis evaluation of AR concentrations in adipose tissue 
as biomarker of whole grain wheat and rye intake was carried out by assessing 
the biomarkers with whole grain intake precisely measured by repeated food 
records during an intervention over a relatively short period of time (12 weeks) 
(Paper II), and with long-term intake of whole grain rye and wheat from single 
(Paper III-V) and repeated FFQs (Paper III). The latter two methods are less 
precise (Kristal et al., 2005), but more practical and frequently applied in 
observational studies (Johansson, 2014). The AR concentration in adipose tissue 
were found to be modestly correlated with total whole grain wheat and rye intake 
or whole grain rye intake, but weakly correlated with whole grain wheat intake, 
most probably due to poor estimation of whole grain wheat in unspecific FFQs. 
These findings suggest that there is room for improvement on whole grain wheat 
intake estimation with FFQ, and specific FFQs with more cereal food items  
could be a good option (Ross et al., 2009). It was found that sex affected AR 
concentrations in adipose tissue (Paper III) and therefore any analysis using AR 
in adipose tissue as biomarkers should be adjusted for sex. 
   In comparison with plasma AR measured in populations with high and frequent 
whole grain intake (Paper II-V), it appears that AR in adipose tissue in AR 
reflect whole grain wheat and rye in a similar way. This may be due to a rapid 
exchange between AR in plasma and adipose tissue and/or due to the accurate 
reflection of long-term AR concentrations in plasma in these populations.  
   Since adipose tissue AR concentrations appeared to reflect whole grain wheat 
and rye in a corresponding way to plasma AR concentrations, their associations 
with relevant endpoints were investigated for the first time (Papers IV and V). 
   A consistent inverse association between AR C17:0/C21:0 ratio in adipose 
tissue or plasma and LDL-C was found in Paper IV which is in agreement with 
results from another study and suggests that whole grain rye rich in viscous fiber 
may have a role in cholesterol reduction. This should be confirmed in dietary 
intervention studies and may open new paths for development of healthy food 
products with health claims.  
   The role of whole grain and cereal fiber in breast cancer prevention is 
controversial. It has been hypothesized, but not proven, that rye, which is also 
rich in lignans, may be of particular benefit. This thesis is the first study to 
investigate the association, using objective biomarkers of whole grain intake. It 
was surprising to find a strong and positive association between higher AR 
C17:0/C21:0 ratio in adipose tissue and risk of developing ER+ breast cancer 
(Paper V). Further studies are needed to replicate this finding in independent 
cohorts and to understand the underlying mechanisms.  
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The two endpoint studies in this thesis support the idea that whole grain wheat 
and rye may have partly different effects on health and that future nutritional 
studies should put more emphasis of the role of separate grains on human health. 
Dietary biomarkers could provide essential and complementary information in 
such analyses and should be used in parallel with conventional dietary 
assessment methods.    
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6 Main findings 
1. A high throughput GC-MS method for determination of alkylresorcinol 
concentrations in adipose tissue biopsies (10-50 mg) was developed, 
evaluated (Paper I), and applied in different studies (Papers II-V). 
 
2. Total alkylresorcinol concentration in adipose tissue responded to reduced 
whole grain intake over a 12wk intervention and correlated well with whole 
grain intake estimated by 3×4-day food records (Paper II). 
 
3. Total alkylresorcinol concentration in adipose tissue was correlated with 
long-term whole grain intake assessed over 14-17 years in free-living 
Swedish men and women. Sex was found to be an important determinant of 
total AR concentration in adipose tissue (Paper III) 
 
4. Alkylresorcinol concentrations in adipose tissue correlated well with fasting 
plasma alkylresorcinol concentrations in the investigated population 
studied, which have high and frequent whole grain intake (Paper II-III). 
 
5. Higher AR C17:0/C21:0 ratios in adipose tissue and plasma, reflecting 
higher proportions of whole grain rye in total whole grain wheat and rye 
intake, were consistently associated with lower low-density lipoprotein 
cholesterol (LDL-C) in blood. These findings are supported by plausible 
mechanisms of LDL-C reduction, but should be confirmed in randomized 
controlled trials (Paper IV). 
 
6. Total whole grain wheat and rye did not appear to be related to risk of 
developing breast cancer. The AR C17:0/C21:0 ratio in adipose tissue was 
positively associated with risk of ER+ breast cancer, but the exact 
mechanism(s) behind this observation remains to be elucidated (Paper V).
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7 Future research 
 
1. Total alkylresorcinol concentration in adipose tissue should be further 
evaluated as long-term biomarkers of whole grain wheat and rye intake in 
subjects with low and infrequent whole grain intake. In such studies, 
whole grain intake should be estimated with methods with higher 
precision, such as repeated weighed food records or specific FFQ with 
more cereal items. 
 
2. Effects of age and body fat composition on alkylresorcinol concentrations 
should be further evaluated in populations with broader age range and 
body fat measurements with dual energy X-ray absorptiometry for both 
genders. 
 
3. The elimination half-life of different alkylresorcinol homologs in adipose 
tissue should be estimated, preferably in populations with no/minimal 
background exposure to alkylresorcinols. 
 
4. Determinants of AR C17:0/C21:0 ratio in adipose tissue should be 
established under controlled intervention conditions. 
 
5. Effects of whole grain rye intake on blood lipid profile should be 
confirmed in human intervention studies. 
 
6. Findings in Paper V should be replicated in an independent population 
and the effects of whole grain rye intake on sex hormone metabolism 
should be examined in animal or human intervention studies. 
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